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A B S T R A C T
Background
Post-traumatic stress disorder (PTSD) refers to an anxiety or trauma- and stressor-related disorder that is linked to personal or vicarious
exposure to traumatic events. PTSD is associated with a range of adverse individual outcomes (e.g. poor health, suicidality) and significant
interpersonal problems which include diGiculties in intimate and family relationships. A range of couple- and family-based treatments
have been suggested as appropriate interventions for families impacted by PTSD.
Objectives
The objectives of this review were to: (1) assess the eGects of couple and family therapies for adult PTSD, relative to 'no treatment'
conditions, 'standard care', and structured or non-specific individual or group psychological therapies; (2) examine the clinical
characteristics of studies that influence the relative eGects of these therapies; and (3) critically evaluate methodological characteristics of
studies that may bias the research findings.
Search methods
We searched MEDLINE (1950- ), Embase (1980- ) and PsycINFO (1967- ) via the Cochrane Common Mental Disorders Controlled Trials Register
(CCMDCTR) to 2014, then directly via Ovid aIer this date. We also searched the Cochrane Central Register of Controlled Trials (CENTRAL)
via the Cochrane Library. We conducted supplementary searches of PTSDPubs (all available years) (this database is formerly known as
PILOTS (Published International Literature on Traumatic Stress)). We manually searched the early editions of key journals and screened
the reference lists and bibliographies of included studies to identify other relevant research. We also contacted the authors of included
trials for unpublished information. Studies have been incorporated from searches to 3 March 2018.
Selection criteria
Eligible studies were randomised controlled trials (RCTs) of couple or family therapies for PTSD in adult samples. The review considered
any type of therapy that was intended to treat intact couples or families where at least one adult family member met criteria for PTSD. It
was required that participants were diagnosed with PTSD according to recognised classification systems.
Data collection and analysis
We used the standard methodological procedures prescribed by Cochrane. Three review authors screened all titles and abstracts and two
authors independently extracted data from each study deemed eligible and assessed the risk of bias for each study. We used odds ratios
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)
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(OR) to summarise the eGects of interventions for dichotomous outcomes, and standardised mean diGerences (SMD) to summarise post-
treatment between-group diGerences on continuous measures.
Main results
We included four trials in the review. Two studies examined the eGects of cognitive behavioural conjoint/couple's therapy (CBCT) relative
to a wait list control condition, although one of these studies only reported outcomes in relation to relationship satisfaction. One study
examined the eGects of structural approach therapy (SAT) relative to a PTSD family education (PFE) programme; and one examined the
eGects of adjunct behavioural family therapy (BFT) but failed to report any outcome variables in suGicient detail — we did not include it
in the meta-analysis.
One trial with 40 couples (80 participants) showed that CBCT was more eGective than wait list control in reducing PTSD severity (SMD
−1.12, 95% CI −1.79 to −0.45; low-quality evidence), anxiety (SMD −0.93, 95% CI −1.58 to −0.27; very low-quality evidence) and depression
(SMD −0.66, 95% CI −1.30 to −0.02; very low-quality evidence) at post-treatment for the primary patient with PTSD. Data from two studies
indicated that treatment and control groups did not diGer significantly according to relationship satisfaction (SMD 1.07, 95% CI −0.17 to
2.31; very low-quality evidence); and one study showed no significant diGerences regarding depression (SMD 0.28, 95% CI −0.35 to 0.90;
very low-quality evidence) or anxiety symptoms (SMD 0.15, 95% CI −0.47 to 0.77; very low-quality evidence) for the partner of the patient
with PTSD.
One trial with 57 couples (114 participants) showed that SAT was more eGective than PFE in reducing PTSD severity for the primary patient
(SMD −1.32, 95% CI −1.90 to −0.74; low-quality evidence) at post-treatment. There was no evidence of diGerences on the other outcomes,
including relationship satisfaction (SMD 0.01, 95% CI −0.51 to 0.53; very low-quality evidence), depression (SMD 0.21, 95% CI −0.31 to 0.73;
very low-quality evidence) and anxiety (SMD −0.16, 95% CI −0.68 to 0.36; very low-quality evidence) for intimate partners; and depression
(SMD −0.28, 95% CI −0.81 to 0.24; very low-quality evidence) or anxiety (SMD −0.34, 95% CI −0.87 to 0.18; very low-quality evidence) for
the primary patient.
Two studies reported on adverse events and dropout rates, and no significant diGerences between groups were observed. Two studies
were classified as having a 'low' or 'unclear' risk of bias in most domains, except for performance bias that was rated ‘high’. Two studies
had significant amounts of missing information resulting in 'unclear' risk of bias. There were too few studies available to conduct subgroup
analyses.
Authors' conclusions
There are few trials of couple-based therapies for PTSD and evidence is insuGicient to determine whether these oGer substantive benefits
when delivered alone or in addition to psychological interventions. Preliminary RCTs suggest, however, that couple-based therapies for
PTSD may be potentially beneficial for reducing PTSD symptoms, and there is a need for additional trials of both adjunctive and stand-
alone interventions with couples or families which target reduced PTSD symptoms, mental health problems of family members and dyadic
measures of relationship quality.
P L A I N   L A N G U A G E   S U M M A R Y
Couple and family therapies for post-traumatic stress disorder (PTSD)
Why is this review important?
PTSD is a severe condition that is linked to both individual and relationship problems. Therapies targeting couples and families have been
recommended for the treatment of PTSD, but it is not clear if these are helpful in reducing trauma symptoms, and other mental health
or relationship problems. The current review is the first attempt to summarise the findings from studies on couple and family therapies
for adults with PTSD.
Who will be interested in this review?
People who suGer from trauma, as well as their families; researchers; and mental health professionals.
What questions does this review aim to answer?
Are couple or family therapies helpful in treating PTSD symptoms and other mental health and relationship problems in comparison to
‘no treatment’ or other types of therapy?
Is there any type of couple and family therapy that is more beneficial than others?
Which studies were included in the review?
We included all published studies of couple and family therapies for PTSD. We found four studies of relevant therapies for adults where
one adult person in the couple/family was diagnosed with PTSD.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)
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What does the evidence from the review tell us?
There were few relevant studies and more research is needed to be sure about the benefits of couple and family therapies for PTSD. The four
studies included in this review provided early suggestion that couple-based treatments may be helpful in reducing trauma symptoms for
the person with PTSD. However, the benefits were not as clear for improving relationship quality or the mental health of family members.
What should happen next?
More studies, including diGerent types of trauma and diGerent types of couple and family therapies for PTSD, are required.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)















































































S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Stand-alone couple or family therapy compared to no treatment for post-traumatic stress disorder
(PTSD)
Stand-alone couple or family therapy compared to no treatment for post-traumatic stress disorder (PTSD)
Patient or population: post-traumatic stress disorder (PTSD)
Intervention: stand-alone couple or family therapy
Comparison: no treatment
Anticipated absolute effects* (95% CI)Outcomes
Risk with no
treatment












Severity of PTSD symptoms - SMD 1.12 lower






Dyadic adjustment - SMD 1.07 higher











Family functioning - - - 0 studies -  
Family member severity of depression - SMD 0.28 higher




VERY LOW 1 2 3
 
Family member severity of anxiety - SMD 0.15 higher




VERY LOW 1 2 3
 
Primary PTSD patient severity of depres-
sion
  SMD 0.66 lower




VERY LOW 1 2 3
 
Primary PTSD patient severity of anxiety - SMD 0.93 lower




VERY LOW 1 2 3
 
Study populationTreatment dropout (treatment acceptabil-
ity)

















































































































































Instances of severe aggression Data omitted from outcome analyses - - -  
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1 Downgraded 1 level due to only one study being available
2 Downgraded 1 level due to small sample: high level of imprecision with large confidence interval
3 Downgraded 1 level due to bias related to self-report measure
4 Downgraded 1 level due to inconsistency between 2 studies
 
 
Summary of findings 2.   Stand-alone couple or family therapy compared to other structured or non-specific intervention for post-traumatic stress
disorder (PTSD)
Stand-alone couple or family therapy compared to other structured or non-specific intervention for post-traumatic stress disorder (PTSD)
Patient or population: post-traumatic stress disorder (PTSD)
Intervention: stand-alone couple or family therapy
Comparison: other structured or non-specific intervention

















Severity of PTSD symptoms - SMD 1.32 lower






Dyadic adjustment - SMD 0.01 higher














































































































































Family functioning - - - 0 Studies -  
Family member severity of depression - SMD 0.21 higher




VERY LOW 1 2 3
 
Family member severity of anxiety - SMD 0.16 lower




VERY LOW 1 2 3
 
Severity of depression - SMD 0.28 lower




VERY LOW 1 2 3
 
Severity of anxiety - SMD 0.34 lower




VERY LOW 1 2 3
 
Study populationTreatment dropout (treatment accept-
ability)









Instances of severe aggression Data omitted from outcome analyses - - -  
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1 Downgraded 1 level due to only 1 study being available
2 Downgraded 1 level due to bias related to self-report measure
3 Downgraded 1 level due to small sample: high level of imprecision with large confidence interval
 
 
Summary of findings 3.   Adjunctive couple or family therapy compared to structured or non-specific individual therapy alone for post-traumatic
stress disorder (PTSD)
Adjunctive couple or family therapy compared to structured or non-specific individual therapy alone for post-traumatic stress disorder (PTSD)









































































































































Intervention: adjunctive couple or family therapy
Comparison: structured or non-specific individual therapy alone
Anticipated absolute effects* (95% CI)Outcomes















Severity of PTSD symptoms - - - (0 studies) -  
Dyadic adjustment - - - (0 studies) -  
Family member severity of depres-
sion
- - - (0 studies) -  
Family member severity of anxiety - - - (0 studies) -  
Severity of depression - - - (0 studies) -  
Severity of anxiety - - - (0 studies) -  
Family functioning - - - (0 studies) -  
Study populationTreatment dropout (treatment ac-
ceptability)










Study populationInstances of severe aggression or
violence
- -
- (0 studies) -  
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect









































































































































1 Downgraded 1 level due to only 1 study being available
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B A C K G R O U N D
Description of the condition
Post-traumatic stress disorder (PTSD) refers to an anxiety or
trauma- and stressor-related disorder where symptom onset is
linked to personal or vicarious exposure to traumatic events.
These include events characterised by sexual violence, or death or
threatened death, as well as actual or threatened serious injury
(American Psychiatric Association 2013). The previous edition of
the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV TR) provides the most commonly used definition in available
research, and defines three categories of symptoms that may
indicate a diagnosis of PTSD (American Psychiatric Association
2000). These include:
1. intrusive re-experiencing of the event (e.g. through flashbacks
and dreams);
2. avoidance of reminders and emotional numbing; and
3. persistent high levels of arousal and reactivity (e.g.
hypervigilance to threat).
These symptom clusters have been re-organised in the recent
fiIh edition of the DSM (DSM-5) (American Psychiatric Association




3. Negative alterations in cognitions and mood
4. Alterations in arousal and reactivity
The revised symptoms thus re-position emotional numbing in a
category that includes negative cognitions (e.g. self-blame) and
emotions, while arousal symptoms are repositioned in a category
including irritable and reckless or self-destructive behaviour
(the latter are new symptoms). Notwithstanding these revisions,
the fundamental construct reflected in the updated criteria is
unchanged (Friedman 2011), whereby close comparability between
DSM-IV and DSM-5 diagnoses is expected (Regier 2013). Most recent
data suggest a lifetime prevalence of PTSD of between 2% to 9% in
the general population (Atwoli 2015), and indicates a disorder that
oIen follows a chronic course (Orcutt 2004; Solomon 2006). PTSD is
associated with a range of adverse individual outcomes (e.g. poor
health, suicidality) (Sareen 2007), and significant interpersonal
problems, including diGiculties in intimate and family relationships
(TaI 2011).
Most evidence linking PTSD to family problems is derived from
studies of military veterans, from Europe and the USA, which
document associations among post-traumatic symptoms and
various adverse relationship outcomes (Galovski 2004). These
include low relationship satisfaction (GoG 2007), family violence
(Glenn 2002), and family members' own mental health problems
(Jordan 1992). Comparative investigations of other trauma-
exposed populations are relatively few, but they also suggest
links between PTSD and problems in intimate relationships. For
example, studies following natural disasters indicate associations
between post-traumatic stress symptoms and poor relationship
adjustment (TaI 2009), while PTSD following interpersonal
victimisation predicts family violence (Krause 2006). Studies of
survivors of childhood sexual abuse also suggest problems with
intimate relationships in adulthood (Cloitre 1997; Lamoureux
2012), including specific diGiculties with intimacy and sexual
dysfunction (Davis 2000). However, the unique influences of PTSD
in the development of these long-term problems remain poorly
understood.
The relationships between PTSD and family problems are likely
to be complex, reflecting both the impact of post-traumatic stress
symptoms on family members, and the eGects of the family
environment on PTSD. On the one hand, avoidance symptoms may
reduce involvement in family activities, while emotional numbing
can inhibit self-disclosure and intimacy (Erbes 2008). Hyperarousal
symptoms are linked to irritability and anger and can also
precipitate aggression and family conflict (TaI 2007a; TaI 2007b).
On the other hand, prospective studies of veterans show that family
relationships can predict change in PTSD (Evans 2009; Evans 2010),
whereby an adaptive family environment can reduce the severity
of symptoms, or exacerbate problems if interpersonal patterns
are dysfunctional. These relationships are likely to be particularly
complex when PTSD is linked to certain types of trauma. These may
include interpersonal trauma (e.g. sexual assault), where couple
relationships may trigger traumatic events, as well as other events
(e.g. natural disasters, motor vehicle accidents) which can impact
directly on multiple family members simultaneously (Riggs 2009).
Description of the intervention
Evidence of associations between post-traumatic symptoms and
family diGiculties has provided impetus for the consideration
of couple and family therapies for PTSD. General reviews of
the literature on couple therapies, such as Baucom 1998 and
Snyder 2006, distinguish two main classes of couple-based
interventions (and by extension, therapies working with broader
family systems). These include (1) generic therapies, developed to
treat distressed relationships and address common interpersonal
problems that can exacerbate individual symptoms, and (2)
disorder-specific interventions, targeting interactions between
interpersonal processes and specific symptoms of the disorder or
its treatment.
Snyder 2006 describes several classes of generic therapies for
distressed relationships that are considered in clinical trials.
First among these are the behavioural therapies (e.g. traditional
behavioural couple therapy) (Christensen 2004), which comprise
techniques for enhancing family members' relationship skills
in problem-solving and communication, and increasing the
frequency of positive interactions. Second are therapies based on
psychodynamic and attachment theory perspectives (e.g. insight-
oriented marital therapy) (Snyder 1989) that are characterised
by a broad focus on developing awareness and expression
of unknown feelings, thoughts and needs that may underlie
interpersonal patterns (Baucom 1998). Other generic therapies
are also available (although considered less oIen in clinical
trials) (Snyder 2006), and can include cognitive strategies for
changing ways of thinking about behaviours and relationships, as
well as techniques for enhancing emotional acceptance. Another
general class of interventions may include 'systemic' therapies
(Coulter 2013), potentially including structural and strategic family
therapies that focus on changing patterns of family interaction and
organisation (Madanes 1981; Minuchin 1974). Integrative therapies
draw from multiple conceptual models (Lebow 1997).
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)
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A number of disorder-specific couple and family therapies for
PTSD have also been proposed and are reviewed by Riggs 2009.
They include therapies based on behavioural principles and
others grounded in cognitive-behavioural models or attachment
theory (Figley 1988; Johnson 1998; Monson 2004; Mueser 1995).
These targeted therapies are commonly oriented towards reducing
partners' distress or dysfunction in the couple relationship, as
well as promoting improvements in individual PTSD. Monson
2004, for example, proposed a stand-alone cognitive-behavioural
treatment for post-traumatic stress symptoms and relationship
functioning that consists of several stages. These initially deliver
psycho-education about PTSD and relationship functioning, and
include behavioural interventions (e.g. communication skills
training) to address avoidance and numbing in the context of
relationships. Subsequent stages comprise scheduled activities
to reduce experiential avoidance and increase positive couple
experiences, as well as dyadic cognitive interventions that target
cognitions maintaining PTSD and relationship problems (Brown-
Bowers 2012). Alternative PTSD-specific interventions comprise
adjunctive therapies that are delivered alongside other primary
psychological and pharmacological treatments (Sautter 2009).
Most of these interventions have been developed in the context
of combat-related PTSD (Monson 2009), with a small number
(such as emotionally focused therapy) proposed originally for use
with victims of sexual or physical abuse (Johnson 1998), or with
traumatised populations more generally (Figley 1988).
How the intervention might work
Given the complex interrelations between post-traumatic stress
symptoms and family adjustment, multiple mechanisms of change
may underlie eGects of couple and family therapies for PTSD. For
example, interventions that enhance relationship skills, including
problem-solving and communication, can equip families to better
manage interpersonal diGiculties such as avoidance of social
situations, and potentially minimise relationship conflicts linked
to PTSD. Therapies which promote family members' mutual
understanding of post-traumatic stress symptoms and its impacts
on relationship dynamics might assist in correcting erroneous
beliefs about interpersonal behaviour and further reduce family
conflict. Interventions that enhance communication, or shared
thoughts and feelings, may facilitate self-disclosure and related
experiences of intimacy (Laurenceau 1998). These therapies will
also operate through common factors shared across interventions
(Sprenkle 2004), and other processes that are relatively unique to
specific clinical models; for example, emotionally focused therapy
which, it is argued, works in part by accessing and reprocessing
negative aGect that underlies problematic patterns (Johnson 1998).
Improvements in individual functioning during therapy, including
reductions in post-traumatic stress symptoms, are expected to
involve various mechanisms. The individual benefits may result
from the reduction of significant negative exchanges within family
relationships (e.g. reflecting high levels of criticism, hostility and
emotional over-involvement) that can act as psychosocial stressors
and exacerbate PTSD (Tarrier 1999). Conversely, couple and family
therapies may promote symptom change by enabling family
members to provide both comfort and social support, the latter
predicting positive adjustment to both physical health problems
and psychological disorders like PTSD (Dirkzwager 2003; Frasure-
Smith 2000; Glass 1992; Kaniasty 2008). With reference to trauma in
particular, Johnson 1998 suggests that comforting and supportive
relationships provide a safe and secure recovery environment
where individuals can reprocess and integrate traumatic memories,
safely experience post-traumatic symptoms (e.g. flashbacks), and
learn to regulate associated negative aGective states.
Why it is important to do this review
Despite a growing research literature on links involving PTSD
and qualities of intimate and family relationships, there remains
limited understanding of the eGects of couple and family therapies
for PTSD in adults. As far as can be ascertained, there is only
one Cochrane Review that has considered family-based therapies
(among others) for PTSD, and this review did not consider
adult samples but focused on children and adolescents (Gillies
2012). Other Cochrane Reviews of interventions for PTSD in
adults have considered psychological therapies (Bisson 2007;
Bisson 2013), pharmacological treatments (Amos 2014; Stein
2006), as well as combined pharmacological and psychological
interventions (Hetrick 2010). A recent review has addressed
psychological interventions for PTSD in people with severe mental
illness (Sin 2017). Other relevant Cochrane Reviews have focused
on prevention of PTSD and treatment of distress immediately
following trauma exposure (Roberts 2009; Rose 2002). None of
these have considered couple or family therapies. This review will
thus provide the first focused examination of best quality clinical
trials of couple and family therapies for PTSD in adults.
O B J E C T I V E S
The objectives of this review were to: (1) assess the eGects
of couple and family therapies for adult PTSD, relative to 'no
treatment' conditions, 'standard care', and structured or non-
specific individual or group psychological therapies; (2) examine
the clinical characteristics of studies that influence the relative
eGects of these therapies; and (3) critically evaluate methodological
characteristics of studies that may bias the research findings.
For purposes of this review, the eGects of interventions were
defined by primary outcomes including PTSD symptoms for the
primary presenting patient, and dyadic adjustment as reported by
the primary presenting patient, family members or clinicians. See
Types of outcome measures for further details on the primary and
secondary outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Eligible studies were randomised controlled trials (RCTs) of couple
or family therapies for PTSD in adult samples. We did not expect
cross-over trials in this context, but were prepared to include
them if couples or families were randomly allocated to treatment
sequence. Cluster-randomised trials were also eligible. We did not
use sample size and the language of the report to determine
inclusion, and there were no restrictions on the study settings that
were eligible for this review. We did not consider quasi-randomised
trials which used non-random methods of allocation to groups
(such as sequential allocation).
Types of participants
Participants were intact couples comprising family members of
any ethnicity or sexual orientation in which at least one adult
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)
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family member (over the age of 18 years) met criteria for PTSD.
Consistent with Lebow 2012, we defined couples as "long-term
committed unions of romantic partners whether or not these
unions are recognised by the state", thus including gay, lesbian
and other long-standing relationships, irrespective of their formal
recognition as 'married'. Although we considered studies of diverse
family structures, we expected that most participants would be
adult couples who are intimate partners in marital or common law
relationships. We did not consider studies where intimate partners
were divorced or separated. Studies of treatments for child or
adolescent PTSD or therapies that focus mainly on family violence
were out of scope.
We required that participants were diagnosed with PTSD according
to recognised classification systems, including the International
Classification of Diseases (ICD-10; WHO 2010), DSM-IV or DSM-5
(American Psychiatric Association 2000; American Psychiatric
Association 2013). Assessment strategies considered appropriate
for ascertainment of PTSD criteria included general clinical
interviews (e.g. based on DSM criteria) and structured clinical
interviews (e.g. Clinician Administered PTSD Scale) (Blake 1995).
We also considered self-report assessment tools (e.g. PTSD
Checklist; Weathers 1993) with validated clinical cut-oGs. If studies
were based on samples in which a subset of participants were
eligible, then these were included if more than 80% of participants
met the inclusion criteria, and were excluded otherwise or if the
proportion of eligible participants was not reported.
Types of interventions
Experimental interventions
The review considered any type of therapy that was intended to
treat intact couples or families where at least one adult family
member met criteria for PTSD. The focus of the review was on
several categories of therapies as described below. We will consider
additional categories of interventions in future updates to this
review as studies become available.
1. Cognitive-behavioural therapies, including interventions based
predominantly on behavioural and cognitive-behavioural
approaches to treatment (Figley 1988; Monson 2004). Therapies
based on pure cognitive approaches were also classified under
this category.
2. Psychodynamic therapies, including interventions based
predominantly on psychodynamic approaches to treatment.
This could include emotion-focused and insight-oriented
therapies (Johnson 1998; Snyder 1989).
3. Systemic therapies, including interventions derived from
general systems theory (von BertalanGy 1969) such as structural
therapies as well as strategic therapies, among others (Coulter
2013; Madanes 1981; Minuchin 1974), and interventions that
draw from multiple systemic frameworks.
4. Integrative therapies, including interventions where
components of treatment were drawn from multiple conceptual
models (Lebow 1997), including those listed above. Where
potential integrative therapies were apparent, initial eGorts
were made to classify the therapy as predominantly one type of
treatment (where around 80% of sessions are dedicated to one
component of treatment). Where it was not possible for us to
classify one predominant type of treatment, we would classify
the intervention as an integrative therapy.
Eligible therapies could be delivered as 'stand-alone' treatments,
as well as 'adjunctive' therapies delivered in conjunction with other
primary treatments (e.g. individual psychological therapy). These
included disorder-specific interventions developed for treatment
of PTSD or associated family diGiculties (Riggs 2009), as well as
generic therapies for relationship discord delivered in the context
of family members with PTSD (Snyder 2006).
For the purpose of this review, we required that interventions were
delivered by psychiatrists, psychologists, counsellors, nurses or
other health professionals with specialist training in family therapy
(including students under supervision). We did not consider group
therapy formats including more than one family 'unit' or studies
where patients mainly attended therapy sessions alone. We did
not place any restrictions based on duration or intensity of the
intervention.
Control conditions
A range of control comparators were potentially eligible, including
'no treatment' controls, 'standard care', and structured or non-
specific individual psychological therapies. For the purpose of
this review, ‘no treatment’ controls refer mainly to wait-list and
assessment-only controls. Standard care refers to a heterogeneous
category of treatments or clinical practices that may be non-
specific and described variously as 'existing practice', 'treatment as
usual' or 'usual care' (Freedland 2011). These may involve relatively
rigorous conditions (e.g. standard of care) or other eclectic
interventions including naturalistic prescribing of medications,
or minor systemic components (e.g. family member psycho-
education).
Structured or non-specific interventions include any manualised
programmes including individual therapies such as those based
on general approaches described in Types of interventions
(e.g. cognitive-behavioural), and other therapies for PTSD (e.g.
eye movement desensitisation and reprocessing) (Bisson 2007;
Bisson 2013) or group-based interventions. Non-specific structured
interventions provide generic features of therapy, including clinical
contact and human interaction (e.g. clinician warmth, empathy,
social support), and a treatment rationale (Mohr 2009). As
such, they may reflect practices that approximate supportive or
humanistic therapy to varying degrees.
We excluded potential studies that compared a couple or
family therapy with an experimental pharmacological treatment
(although comparisons with individual therapies that involve
naturalistic prescribing of medications were eligible).
Types of outcome measures
The review considered outcomes addressing multiple domains of
individual, couple and family adjustment. Additional outcomes,
such as marital stability, observational measures of marital
interaction, parental functioning measures or other outcomes
related to how trauma interacts with the family system, as well
as potential adverse events (e.g. substance abuse, self-harm/
suicidality/suicide) may be considered in updates to this review as
further studies become available.
Primary outcomes
1. Severity of PTSD symptoms for the primary presenting
patient, ascertained using self-reports or clinician reports on
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
measurement scales such as the PTSD Checklist (Weathers
1993), the PTSD symptom scale (Foa 1993), as well as the
Clinician Administered PTSD Scale (Blake 1995). The last
is considered a 'gold standard' measure in many contexts
(Weathers 2001).
2. Dyadic adjustment, ascertained using self-report, family
member reports or clinician reports on measures of relationship
satisfaction or distress, like the Dyadic Adjustment Scale or the
Marital Adjustment Test (Locke 1959; Spanier 1976).
Secondary outcomes
1. Severity of anxiety or depression (or both) of family
members, ascertained using self-reports or clinician reports on
measurement scales such as the Beck Depression Inventory
or the Beck Anxiety Inventory (Beck 1961; Beck 1988); or of
psychological distress (measured by, for example, the five-item
Mental Health Index of the 36-item Short Form health survey
(SF-36); Ware 2000). We intended to consider data from adult
intimate partners and children separately where suGicient data
were available.
2. Severity of co-occurring depression or anxiety (or both),
as demonstrated by the primary presenting patient and
ascertained using self-reports or clinician reports on
measurement scales such as the Beck Depression Inventory or
the Beck Anxiety Inventory (Beck 1961; Beck 1988).
3. Overall family functioning, ascertained using self-report,
family member reports or clinician reports of overall family
functioning, or specific characteristics of family interaction (e.g.
communication), as measured through scales like the McMaster
Family Assessment Device or the Family Environment Scale
(Epstein 1983; Moos 1986).
4. We used treatment dropout as a proxy measure of treatment
acceptability, and defined it as the proportion of participants in
treatment and control conditions that provided data at the most
immediate post-treatment assessment.
5. Instances of severe aggression or violence were considered as
a type of adverse event (see Christensen 2005). Other types
of adverse events (e.g. substance abuse, self-harm) may be
considered in updates of this review as data becomes available.
Multiple informants
When data on dyadic adjustment or family functioning were
available from multiple family members (e.g. when both partners in
a couple reported on relationship satisfaction), we combined data
from multiple informants and used the simple arithmetic mean of
scores (assuming that all family members provided reports on the
same scale) and pooled variance. We considered exceptional cases
to be where diGerent family members showed widely divergent
perspectives on relationships, as demonstrated by limited shared
variance (i.e. < 50% or r = 0.70). In such instances, we considered
reports from diGerent family members in separate analyses. We
intended to examine the implications of decisions to average
across multiple informants through sensitivity analyses, where
appropriate.
Timing of outcome assessment
We examined data from outcomes at immediate post-treatment
assessments, conducted from 0 to 3 months following completion
of therapy. We will consider follow-up assessments — conducted
more than 3 months but less than 12 months following completion
of therapy, and longer periods of follow-up — in future updates
when data becomes available.
Search methods for identification of studies
We conducted a systematic search to identify all available relevant
studies. The search comprised two main strategies: (1) electronic
searches of databases and clinical trials registries; and (2) manual
searches of other resources.
Electronic searches
We performed electronic searches of the following bibliographic
databases to 3 March 2018:
• Ovid MEDLINE (1950 onwards);
• Ovid Embase (1974 onwards);
• Ovid PsycINFO (1967 onwards);
• Cochrane Common Mental Disorders Controlled Trials Register
(CCMDCTR) (all years to June 2016 (only));
• Cochrane Central Register of Controlled Trials (CENTRAL) (via
the Cochrane Library;
• Proquest PTSDPubs (formerly known as PILOTS (Published
International Literature on Traumatic Stress)) (all available
years).
Searches of MEDLINE, Embase and PsycINFO were initially
conducted via the Cochrane Common Mental Disorders Controlled
Trials Register (CCMDCTR) to June 2016. However aIer the CCMDCR
fell out of date (June 2016 onwards ) searches were conducted
directly on these databases via the Ovid platform, with an overlap
from 2014 to date.
The CCMDCTR was searched (all years to June 2016) using the
following free-text terms:
(PTSD or post-trauma* or *trauma* or "stress disorder*" or (combat
and disorder*) or (war and neuro*)) AND (couple* or partner*
or marriage or marital or husband* or wife or wives* or spous*
or family or families or multi-family or conjoint or interpersonal
or relations* or “significant other*” or (child* and parent*)) AND
(*therap* or counsel* or treat* or intervention*)
For a full description of the CCMDCTR, please see Appendix 1.
Consistent with the CCMDCTR search strategy, we applied RCT
filters on searches across the other databases to limit the results to
controlled trials (as appropriate). We adapted the search terms to
conduct analogous searches of PILOTS/PTSDPubs.
The database searches conducted in March 2018 (Appendix 2) were
part of a much larger search (based on population alone) for a suite
of PTSD reviews within CCMD.
We also searched the World Health Organization (WHO)
International Clinical Trials Registry Platform (ICTRP)
search portal (apps.who.int/trialsearch) and ClinicalTrials.gov
(ClinicalTrials.gov) to identify unpublished and/or ongoing studies
(to February 2019).
We applied no restrictions based on date, language, or publication
status to the searches (other than those described above).
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We conducted an update search (22 February 2019) (Appendix 3)
with terms tailored to couple and family therapies for PTSD. The




We manually searched the early editions of key journals to identify
potentially relevant studies that were not indexed in the databases.
These journals included:
1. Journal of Traumatic Stress (1988 to 2000);
2. Journal of Family Psychology (1987 to 2000); and
3. Journal of Marital and Family Therapy (1980 to 2000).
Reference lists
We manually screened the reference lists and bibliographies of
all included studies to identify other relevant references. We also
contacted all authors of included studies for any unpublished or
ongoing studies, or studies not otherwise identified in the search.
Data collection and analysis
Selection of studies
We reviewed and selected studies in several stages. First, we
screened the titles and abstracts (where available) of all records
retrieved to determine potentially eligible studies. Three review
authors (AS, SC, ST) screened all titles and abstracts; two reviewers
screened each record. Where there were disagreements, the third
author also reviewed the record. The alpha for interrater reliability
between two authors for the first screening stage was above 0.95.
We obtained full-text articles of any studies that seemed to meet
inclusion criteria, as well as those that could not be excluded
based on title and abstract. Two review authors (AS, SC) then
independently examined each full-text article in order to confirm
eligibility and resolved any disagreements through discussion. We
identified any duplicate (secondary) publications and listed them
alongside the primary publication. We recorded and presented
decisions made during the study selection process, as well as the
names and numbers of studies and reasons for exclusion at each
stage, in a PRISMA flow diagram.
Data extraction and management
We extracted data on the characteristics of eligible studies from
reports using a piloted, structured data extraction template. This
addressed information (where available) relating to publication
details (e.g. country of origin, year of publication), sample
characteristics (e.g. age and ethnicity of participants, predominant
type of trauma), clinical characteristics (e.g. type of therapy,
duration of treatment), methodology (e.g. inclusion/exclusion
criteria, timing of follow-up assessments), statistical analyses
and results (e.g. strategies for managing non-independent data
from family members, group means and standard deviations for
primary and secondary outcomes). Two review authors (AS, SC)
independently extracted data from each study.
Main comparisons
We planned multiple comparisons to evaluate the eGects of stand-
alone couple or family therapies for PTSD, compared to relevant
control comparators. These included:
1. stand-alone couple or family therapy versus no treatment;
2. stand-alone couple or family therapy versus standard care; and
3. stand-alone couple or family therapy versus other structured or
non-specific intervention.
Additional comparisons were planned to evaluate the eGects
of adjunctive couple or family therapies, additional to primary
treatment, relative to controls. These included:
1. adjunctive couple or family therapy versus standard care; and
2. adjunctive couple or family therapy versus structured or non-
specific individual therapy alone.
Additional types of comparisons may be considered as studies
become available.
Comparisons involving adjunctive therapies were limited to
control conditions that involved substantively similar primary
treatments. We therefore did not consider comparisons between
couple or family therapies adjunctive to primary treatment
and (a) 'no treatment' controls, and (b) substantively diGerent
primary treatments (e.g. cognitive-behavioural therapy versus
psychodynamic individual therapy). Where multiple couple or
family therapy conditions were compared with control conditions,
it was intended that couple or family therapy conditions would be
combined (Unit of analysis issues).
Assessment of risk of bias in included studies
Two review authors (AS, SC) independently assessed the risk of bias
associated with each study. Both authors allocated a judgement of
'High', 'Low' or 'Unclear' risk of bias with regard to several design
characteristics that are among the main sources of bias in clinical
trials (Higgins 2017). We resolved disagreements with regard to
classification of bias through discussion. In line with available
recommendations (Juni 1999), we assessed each source of bias
independently.
Random allocation to groups (sequence generation)
One of the eligibility requirements included random allocation of
studies to groups. Notwithstanding this, we envisaged that the
level of detail published about randomisation procedures would
vary. We classified studies which provide limited or no detail about
randomisation as having unclear risk of bias.
Allocation concealment
Adequate concealment of allocation requires that participants and
researchers are kept unaware, and are unable to foresee the groups
to which participants are allocated (Schulz 2002). We classified
studies that lack allocation concealment as having high risk of bias.
Blinding
Blinding can refer to hiding the nature of the intervention delivered
from multiple potential groups (e.g. participants, treatment
providers, outcome assessors) (Montori 2002). We considered the
following blinding aspects.
1. Participants and treatment providers: blinding of participants
and treatment providers can be accomplished in studies
of pharmacological treatments, but it is rarely feasible for
psychosocial therapies. Accordingly, we expected that most
studies would be classified as having a high risk of bias
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2. Outcome assessors: this refers to masking of group allocation
from outcome assessors, such as researchers administering
symptom scales. Studies that failed to blind outcome assessors
(including studies relying on self-report measures completed by
participants) were classified as having a high risk of bias. Given
that blinding of outcomes assessors may vary within studies
and across outcomes (e.g. some may be self-reported with
other outcomes evaluated using blinded outcome assessors),
we assessed this characteristic separately for each outcome
considered in Types of outcome measures.
Incomplete outcome data
According to Higgins 2017, missing data can be caused by both
study exclusions and attrition. Justifiable reasons for exclusions
may include identifying (aIer randomisation) that participants
were ineligible for the study. In contrast, participants may be
excluded because they did not receive the intended intervention
in accordance with the protocol (or for other reasons), which may
lead to bias (Higgins 2017). In case of missing data from attrition,
primary studies may report analyses conducted using data from
participants providing complete information (i.e. 'completers
only'), or by including data from all participants through use
of various missing data strategies. These include recommended
strategies based on principles of maximum likelihood or multiple
imputation, as well as older (and potentially biased) forms of
imputation, including mean imputation and last observation
carried forward (LOCF) (Graham 2009).
For the purpose of this review, we classified studies as having a high
risk of bias if they violated any of three principles of intention-to-
treat (ITT) analyses described by Higgins 2017. These are:
1. "keep participants in the intervention groups to which they were
randomised, regardless of the intervention they received";
2. "measure outcome data on all participants"; and
3. "include all randomised participants in the analyses".
Given that approaches to managing incomplete outcome data
(from attrition in particular) may vary within studies and across
outcomes, we assessed these approaches separately for each
outcome considered in Types of outcome measures.
Selective outcome reporting
Selective outcome reporting refers to the presentation of a limited
subset of data or analyses based on the nature (e.g. statistical
significance) of results (Hutton 2000). Although there are various
issues suggestive of selective outcome reporting (Higgins 2011b),
we classified studies in this review as having high risk of bias if
they had protocols or entries in trial registries that list primary
or secondary outcomes that diGer from those reported in the
published results (lacking credible explanation). We classified
studies that were not associated with published protocols or
adequately detailed entries in trial registries as having an unclear
risk of bias.
Other sources of bias
We assessed each study for any other problems that could put it at a
high risk of bias including bias relating to the study design or claims
of fraudulence, or other sources of bias that are not covered in the
other sources of bias above.
Measures of treatment e;ect
Dichotomous data
For evaluation of treatment eGects based on dichotomous
outcomes (e.g. scores in the clinically significant range on
relationship adjustment), we used risk ratios (RRs) and associated
95% confidence intervals (CIs).
Continuous data
For evaluation of treatment eGects based on continuous outcomes
we used mean diGerences (MDs) where outcomes were reported on
the same scale, or the standardised mean diGerence (SMDs) where
outcomes were reported on diGerent scales. We obtained SMDs by
calculating the diGerence between raw means and dividing by the
pooled variance of treatment and control conditions. We used 95%
CIs around the MDs or SMDs.
Unit of analysis issues
Cluster-randomised trials
If a cluster-randomised trial had been identified, we would
have extracted the methods used to analyse data, and use the
inflated standard error approach to adjust standard errors for non-
independence of observations (Higgins 2011b). To facilitate this, we
would have extracted the degree of non-independence, as reflected
in the intra-class correlation (ICC). Where the ICC is not reported, we
would intend that a value of 0.05 would be assumed.
Cross-over trials
Where a cross-over trial was identified, we intended that data from
the between-group comparison from the first treatment stage only
would be considered.
Studies with multiple treatment groups
Where multiple couple or family therapy conditions were compared
with a 'no treatment' or individual intervention control, we planned
to combine the couple or family therapy conditions using the
formulae reported by Higgins 2011a. Exceptions would be where
a stand-alone couple or family therapy and adjunctive therapy
(alongside another primary treatment) were both compared
with an individual therapy condition, and where the adjunctive
condition provided a significant additional dosage of therapy
in terms of number of sessions. Rather, we evaluated stand-
alone and adjunctive therapy conditions in separate comparisons
(Data extraction and management). Where diGerent groups were
involved in the same treatment, but have results reported
separately, it was intended that we would combine these data.
Dealing with missing data
Missing information about study design and results/statistics
We initially gathered Information about research design that was
not reported in a primary publication through examination of
duplicate publications. Where informative duplicate publications
were unavailable, and where missing data related to the inclusion
criteria or risk of bias (as defined in this review), we contacted
the study authors for additional information. We also sought
clarification from the study authors where statistics necessary for
the estimation of treatment eGects (e.g. standard deviations) were
missing.
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Missing observations from primary studies due to attrition
Our decision to consider 'completers only' data or data from all
participants was initially determined by the type of information
reported; for example, where the study only reported analyses of
the 'completers only' sample. However, we gave preference to data
from all randomised participants (where available). Given certain
'old' missing data strategies (such as mean or single imputation or
LOCF) that may still introduce bias into the study (Graham 2009),
we examined these through sensitivity analyses.
Assessment of heterogeneity
Clinical heterogeneity
For studies that were clinically heterogeneous or presented
insuGicient information to facilitate quantitative synthesis, we
presented a narrative summary of results.
Statistical heterogeneity
Given a suGicient number of studies, we planned to assess
statistical heterogeneity using the I2 statistic, which indicates the
percentage of total variability across studies that is due to between-
study diGerences (Huedo-Medina 2006). Although thresholds for I2
are arbitrary, there are overlapping bands that suggest minor (0%
to 40%), moderate (30% to 60%), substantial (50% to 90%), and
considerable (75% to 100%) levels of heterogeneity (Deeks 2011).
Interpretation of the I2 statistic is qualified through evaluation
of the pattern of variability, and whether all studies indicate
beneficial eGects of treatment. Where strong evidence of true
heterogeneity was present, we considered the pooled eGect as
a limited, although 'best available' estimate of the expected
magnitude of the treatment eGect.
Assessment of reporting biases
We examined multiple databases to identify published research,
and searched trial registers to identify unpublished studies. We
intended that funnel plots and linear regression tests would be used
to evaluate publication bias if there were more than 10 studies
available (Egger 1997; Sterne 2011). We also screened relevant
databases and trial registers to identify reports published in a non-
English language.
Data synthesis
Two authors (AS, SC) entered data into the Cochrane statistical
soIware, Review Manager 2014, and employed the random-
eGects model to provide weighted estimates of the eGects of
each intervention relative to control. This random-eGects model
assumes true variability in eGect sizes across studies, and estimates
both the average eGect and degree of variability across studies
(Normand 1999). Where there is evidence of true heterogeneity, it
may be inappropriate to place inordinate emphasis on a weighted
mean eGect size (especially if some studies indicate harmful
eGects), and we thus qualified the pooled estimates through
discussion of statistical diversity of studies.
Subgroup analysis and investigation of heterogeneity
In the case of observed statistical heterogeneity, we planned to
pursue subgroup analyses to examine factors explaining between-
study variability, which included the following.
1. Disorder-specific versus generic couple or family therapies:
disorder-specific and generic therapies share a focus on
improved relationship outcomes. However, disorder-specific
therapies may include components of treatment targeting
individual psychopathology, and may thus have greater impacts
on individual post-traumatic stress symptoms. The more
singular focus of generic therapies on relationship problems
may lead to larger improvements in couple and family
adjustment.
2. Nature of trauma linked to disorder onset: patients exposed
to interpersonal trauma (e.g. sexual assault) may demonstrate
greater severity of problems in couple and family functioning,
relative to traumas that do not have equivalent interpersonal
components (e.g. combat exposure, natural disasters).
Accordingly, disorders associated with interpersonal trauma
may benefit more from couple and family therapies.
3. Recent onset versus chronic PTSD: disorders with recent onset
(e.g. within one year of trauma exposure) may be more
amenable to change following couple and family therapies for
PTSD, relative to longer-standing conditions where symptoms
and interpersonal patterns have become established over time.
We intended to carry out subgroup analyses where at least 10
studies were available, and planned to use the approach described
by Deeks 2011, applying the test for subgroup diGerences available
in Review Manager 2014. We may consider other potential clinical
characteristics (e.g. couple versus family-based therapies for PTSD)
in updates as studies and literature becomes available.
Sensitivity analysis
We conducted sensitivity analyses to examine whether findings
were robust to approaches adopted in this review (Deeks 2011).
The following characteristics of assumptions were considered
sequentially for the purposes of these analyses.
1. Where outcome data from multiple informants are available, we
excluded data from family members.
2. We excluded cluster randomised trials.
3. We varied the ICC used during analyses of cluster randomised
trials.
4. We excluded cross-over trials.
5. We excluded results based on ‘completers only’.
We may include additional sensitivity analyses based on
methodological quality of studies as more evidence becomes
available. For the current review, there were too few trials to
undertake sensitivity analyses on the basis of risk of bias.
'Summary of findings' table
We developed the 'Summary of findings' table to summarise
the key findings of the review, for all relevant populations, in
line with Schünemann 2011. We used the GRADE approach to
interpret findings and used GRADEpro to import data from Review
Manager 5 to create the 'Summary of findings' table. Summary
of findings for the main comparison presents findings relating
to each type of intervention in terms of primary and secondary
outcomes (Types of outcome measures) for our main comparison,
Comparison 1. Summary of findings 2 presents the outcomes for
the other comparison we had data available, Comparison 3. The
tables present standardised eGect size estimates (and 95% CIs) to
illustrate comparative risk, the number of studies and participants,
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and the quality of evidence based on standards of the GRADE
working group (Balshem 2011). Given the general absence of
evidence due to a low number of included studies, the certainty of
evidence ranges from low to very low across the outcomes.
R E S U L T S
Description of studies
Results of the search
Searches of the CCMDCTR and other databases to 3 March 2018
yielded 1246 records to screen (aIer the removal of duplicates).
Three authors (AS, SC and ST) reviewed titles and abstracts
and obtained full-text versions of 24 articles (including four
ClinicalTrials.gov protocols). Four studies (five references) met the
inclusion criteria and we included them in the analysis. Figure 1
presents the PRISMA diagram for the study review process. We
contacted all the authors (4) for additional information and one
responded to queries.
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Figure 1.   Study flow diagram (results to March 2018).
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Figure 1.   (Continued)
 
In February 2019 a further update search identified 327
references. Among these references, we found new updated
results (as of November 2018) of a study we had previously
classified as 'ongoing' (NCT01035788), we subsequently moved
this study to Characteristics of studies awaiting classification,
and will incorporate it at a later date, as appropriate. Personal
communication (March 2019) with the main author of this trial
(NCT01035788) indicated that the main outcome publication will be
available in late 2019.
Included studies
We included four studies in the review, although one study reported
data on relationship satisfaction only (and no other outcomes)
(Ahmady 2009), while one study reported baseline information on
pre-specified outcomes only, and no post-treatment data (Glynn
1999). Two studies provided data on a range of primary and
secondary outcome measures at post-treatment (Monson 2012;
Sautter 2015). We describe the characteristics of these studies
below (see also Characteristics of included studies).
Design
All included studies were described as randomised controlled/
clinical trials. Sautter 2015 used a ‘simple’ type of randomisation
to SAT and PFE conditions while Monson 2012 used a computer
random number generator to allocate participants to wait list
and treatment. Glynn 1999 adopted a three-group design (one
adjunctive therapy group, one individual therapy group only and
one control group) and reported using a sequential random
balancing strategy with a modification of randomisation odds to
permit 50% likelihood of being assigned to the adjunctive therapy
group, and 25% chance of being assigned to the two other groups.
In three studies participants and personnel were not blinded
and were thus aware of the intervention conditions (Glynn 1999;
Monson 2012; Sautter 2015). Ahmady 2009 did not report about
randomisation method or blinding of the participants.
One trial comprised 9 weeks of individual therapy followed by
adjunct family therapy (16 to 18 sessions) with post-treatment
assessments scheduled immediately aIer treatment and at 6
months (Glynn 1999). Two trials were conducted over a 12-week
period, and included pre-treatment, post-treatment (immediately
aIer 12-week treatment) and 12-week follow-up assessments
(Monson 2012; Sautter 2015). Monson 2012 included one mid-
treatment assessment at four weeks; and Sautter 2015 included
two mid-treatment assessments at three and six weeks into the
programme. Ahmady 2009 was conducted over 6 months (16 to
18 sessions) and reported post-treatment assessment immediately
aIer the intervention (with no other indication of the timing of
assessments).
Setting
Three studies were two-site trials run out of outpatient veterans'
mental health services, including two diGerent outpatient veterans'
mental health services (Ahmady 2009; Sautter 2015), and one
outpatient veterans' mental health service and a university-based
mental health clinic (Monson 2012). One study did not specify
the number of sites but they reported that the treatment was
embedded in Veterans' AGairs customary care in Los Angeles (Glynn
1999). The sites were situated in the USA (Glynn 1999), Iran (Ahmady
2009), Canada (Sautter 2015), and the USA and Canada (Monson
2012).
Participants
The four studies included a total of 186 couples/family units (372
individuals). Glynn 1999 included 29 male veterans who were in
military service during the Vietnam conflict and met criteria for
PTSD, and their family members. Sautter 2015 included 57 veterans
with PTSD and their intimate partners, while Monson 2012 sampled
40 couples in which one partner met criteria for PTSD (including
veterans and members of the general community). Glynn 1999,
Monson 2012 and Sautter 2015 used the Clinician Administered
PTSD scale (CAPS: Blake 1995; Weathers 2001) and Ahmady 2009
used PTSD Checklist (PCL; Weathers 1993) to screen for PTSD
at baseline. Glynn 1999, Monson 2012 and Sautter 2015 asked
participants to refrain from other psychological therapy (couples
or individual) and to maintain a stabilised regimen of psychotropic
medications. Monson 2012 and Sautter 2015 reported outcomes for
both primary patients with PTSD and their intimate partners; Glynn
1999 and Ahmady 2009 only reported outcomes in relation to the
primary patient.
The mean age for primary patients with PTSD was 38.9 years (SD
= 7.2) and mean age for partners was 35.6 years (SD = 7.5); Glynn
1999 did not report the age of the family members. Only Sautter
2015 and Monson 2012 reported the gender of participants; the
primary patients with PTSD were predominantly male (68.1%) and
partners were predominantly female (69.1%). Family members in
Glynn 1999 were predominantly female partners, with two siblings
and two parents. Sautter 2015 included opposite-sex partners but
only those who had been either married for at least three years
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or in an intimate partnership for six or more consecutive months.
Monson 2012 included both same and opposite sex partners and
no minimum time requirement for the length of the relationship.
Ahmady 2009's couples had been married for a minimum of 3 years
at the beginning of the trial.
Interventions
Description of each manualised intervention
Both Glynn 1999 and Ahmady 2009 followed the Behavioural Family
Therapy (BFT) protocol detailed in Mueser & Glynn 1999, which
consisted of 16 to 18 sessions across five phases: (1) orientation
and general evaluation of the primary patient and spouse (three
sessions); (2) education about PTSD and complications related
to the course of the disorder (two sessions); (3) communication
training on how to express feelings and ideas (three sessions);
(4) anger control (two sessions); and (5) problem solving abilities,
strategies, techniques to manage and confront new problems (6 to
8 sessions).
Monson 2012 described a Cognitive Behavioural Conjoint Therapy
(CBCT) protocol which comprised 15 sessions organised in three
phases: (1) establishing a rationale for therapy and safety within
the relationship, involving psychoeducation about facilitating a
shared sense of safety through recognition of early signs of conflict
and conflict management strategies (twice-weekly sessions); (2)
enhanced dyadic communication skills training to identify and
share feelings and thought patterns (twice-weekly sessions); (3)
developing propensities to approach rather than avoid thoughts
that may contribute to PTSD symptoms (weekly sessions).
Sautter 2015 described a Structured Approach Therapy (SAT)
protocol comprising 12 sessions organised in three phases: (1)
psychoeducation and strategies for facilitating a shared sense
of safety through recognising early signs of conflict and conflict
management strategies (twice-weekly sessions); (2) enhanced
dyadic communication skills to identify and share feelings
and symptomatic thought patterns (twice-weekly sessions); (3)
development of propensities to approach rather than avoid
thoughts that may contribute to PTSD symptoms (weekly sessions).
In three studies, clinicians who delivered the intervention
were therapists with postgraduate-level clinical training or post-
graduate students under the supervision of trained clinicians
(Glynn 1999; Monson 2012; Sautter 2015). Ahmady 2009 did not
report details on the delivery of the intervention.
Comparison groups
Description of a comparison group was available for three studies.
Glynn 1999's individual therapy control included a 9-week directed
therapeutic exposure (DTE), whereby BFT was delivered as an
adjunct therapy following the DTE trial (i.e. the two therapies
were not run simultaneously). The DTE included twice-weekly 90-
minute sessions over a 9-week period (18 sessions in total) that
proceeded from building therapeutic alliance and identifying the
two most anxiety-provoking events for purposes of the subsequent
re-exposure and cognitive restructuring stage. The latter involved
a review of the traumatizing events in detail to permit extinction
of arousal associated with memories and relevant cues. AIer the
patient had completed at least six trials of exposure on each of
the two traumatising events, the therapist allocated 15 minutes
of each session to cognitive restructuring of memories, correcting
distortions and normalizing trauma aGects and behaviour. Glynn
1999 also included a wait-list condition which was not considered
in this review (see Data collection and analysis).
Monson 2012 used a 3-month waiting list control condition. Sautter
2015 employed an active comparator which comprised PTSD Family
Education (PFE). The latter comprised 12 weekly sessions which
were equal to the target intervention (SAT) in terms of number and
duration. The aim was to educate the veteran and their partner
about PTSD through lectures, discussions and written materials.
Clinicians providing PFE were instructed to avoid delivering skills
training and other therapeutic interventions.
Outcomes
Three studies reported data on PTSD severity and dyadic
adjustment (or relationship satisfaction) as reported by the primary
patient with PTSD (Glynn 1999; Monson 2012; Sautter 2015). Two
studies also reported data on dyadic adjustment/relationship
satisfaction and psychological symptoms (depression, anxiety) as
reported by the partner, as well as the primary patient with PTSD
(Monson 2012; Sautter 2015). Ahmady 2009 reported data on dyadic
adjustment and not on other outcomes.
Adverse events reported in two studies were instances of intimate
partner violence and treatment dropouts (Monson 2012; Sautter
2015). Glynn 1999 also reported dropout rates. On all psychosocial
outcome measures described in this section, higher scores indicate
greater symptom severity.
Primary outcome 1: severity of PTSD symptoms
Three studies — Glynn 1999, Monson 2012 and Sautter 2015
— operationalised overall PTSD symptom severity using the
CAPS (Blake 1995; Weathers 2001), although Glynn 1999 reported
findings relating to the baseline assessment only. Ahmady 2009
used the PCL to measure PTSD severity (Weathers 1993), but also
reported comparisons conducted at baseline only.
Primary outcome 2: dyadic adjustment/relationship satisfaction as
reported by primary patient and partner
All four studies reported data relating to dyadic adjustment/
relationship satisfaction. Ahmady 2009 used the ENRICH marital
satisfaction scale (EMS; Fowers 1993) which consists of 15 questions
about diGerent aspects of marital adjustment. Ahmady 2009 did not
report details on the method of scoring of these items and they did
not report the means and standard deviations for scores (rather,
they reported mean diGerences for intervention and control groups
at post-treatment).
Monson 2012 and Sautter 2015 used the Dyadic Adjustment Scale
(DAS; Spanier 1976) to assess relationship adjustment, as reported
by both the primary patient with PTSD and their partners. Glynn
1999 also used the DAS which was reported by the primary patient
and at baseline only. The DAS is a 32-item self-report measure with
scores ranging from 0 to 151, with higher values indicating higher
relationship satisfaction. When DAS scores were reported by both
the primary patient and their partner (Monson 2012; Sautter 2015),
we used the arithmetic mean of scores (and pooled variance) for
purposes of analyses.
Secondary outcome 1: family member severity of depression
Two studies reported findings relating to the severity of depression
for partners (Monson 2012; Sautter 2015). Sautter 2015 used
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partner reports on the Center for Epidemiologic Studies Depression
Scale (CES-D; RadloG 1977), which is a 20-item self-report measure
designed to assess depressive symptoms in non-clinical settings.
Monson 2012 used partner reports on the Beck Depression
Inventory (BDI; Beck 1988).
Secondary outcome 2: family member severity of anxiety
Sautter 2015 reported state anxiety symptoms for partners which
were measured using the state subscale of the Spielberger State–
Trait Anxiety Inventory (Spielberger 1988). This subscale (STAI-
State) consists of 20-items which are self-reported. Monson 2012
also used the Spielberger 1988 measure to assess partner anxiety,
but determined trait (rather than state) anxiety using the 20-item
STAI-Trait subscale.
Secondary outcome 3: severity of co-occurring depression or anxiety
of the person with PTSD
Sautter 2015 measured depression severity for the primary patient
with PTSD using the Center for Epidemiologic Scale for Depression
(CES-D; RadloG 1977), while anxiety symptoms were measured
using the STAI-State (Spielberger 1988). Monson 2012 used STAI-
Trait (Spielberger 1988) to measure trait anxiety and the BDI (Beck
1988) to measure depression severity for the primary patient with
PTSD.
Secondary outcome 4: overall family functioning
No studies measured overall family functioning or specific
characteristics of family interaction (e.g. communication).
Secondary outcome 5: treatment dropout
We used treatment dropout rates as a proxy measure of treatment
acceptability; they were defined as the proportion of participants
in treatment and control conditions that provided data on the
most immediate post-treatment assessment. Glynn 1999, Monson
2012 and Sautter 2015 reported data which informed calculation of
treatment dropout rates, while Ahmady 2009 did not.
Secondary outcome 6: instances of severe aggression
Instances of severe aggression were considered as a type of adverse
event. In Monson 2012, endorsement of any severe physically or
sexually aggressive behaviour as defined by the Conflict Tactics
Scale–Revised (CTS2; Straus 1996) in the past year excluded
couples from the study. Sautter 2015’s exclusion criteria for both
partners included physical aggression with injury to a partner
during domestic violence as also measured on the Physical Assault
subscale of the CTS2. Both studies reported one incident of intimate
partner violence that occurred during the trials.
Excluded studies
We excluded ten studies following review of the full-text, as they
did not satisfy the inclusion criteria with the following primary
reasons: Three studies (Cahoon 1984; Knox 2016; Landy 2015) did
not allocate participants randomly into two or more groups. Four
studies (Holditch-Davis 2014; Jones 2004; Jones 2012; Kersting
2013) did not include couple's or family therapy and the remaining
studies did not measure PTSD for adult participants: King 2000
included measure of PTSD for maltreated children and two studies
(Heinrichs 2012; Zimmermann 2016) involved couple's in the
context of cancer treatment without a PTSD measure. More detail of
the excluded studies is available in the Characteristics of excluded
studies table.
Ongoing studies
There is one ongoing study detailed below.
Cognitive behavioural conjoint therapy (CBCT) Project
This randomised controlled trial commenced in 2016 with an
estimated completion date in 2020 (NCT02720016). The study aims
to enrol 180 couples (360 participants) in which one partner is a
PTSD-positive veteran. The aim of the trial is to compare home-
based CBCT to two active comparators: oGice-based CBCT and
PTSD family education (PFE).
Primary outcome measures
1. PTSD symptoms as measured by CAPS at post-treatment and 3-
month and 6-month follow-up.
2. Relationship satisfaction as measured by Couples Satisfaction
Index (CDI) at mid- and post-treatment, 3-month and 6-month
follow-up.
3. Functional impairment as measured by Inventory of
Psychosocial Functioning (IPF) at post-treatment and 3-month
and 6-month follow-up.
4. Client Satisfaction Questionnaire (CSQ) at post-treatment.
Secondary outcome measures
1. PTSD Checklist-5 (PCL-5) at mid- and post-treatment, 3-month
and 6-month follow-up.
2. Beck Depression Inventory-II (BDI-2) at mid- and post-
treatment, 3-month and 6-month follow-up.
3. State-Trait Anger Inventory (STAXI) at mid- and post-treatment,
3-month and 6-month follow-up.
4. Conflict Tactics Scale Short Form (CTS-2S) at mid- and post-
treatment, 3-month and 6-month follow-up.
Studies awaiting classification
There are three studies awaiting classification.
1. E;ects of mindfulness-based cognitive-behavioral conjoint therapy
on post-traumatic stress disorder and relationship function
We identified this randomised controlled trial, commenced in 2010,
in the initial search as an ongoing study and the outcomes were
first published in ClinicalTrials.gov (NCT01035788). The goal of
this study was to examine the eGects of a mindfulness-based
adaptation of CBCT for PTSD (MB-PTSD). Forty-six OEF-OIF Veterans
and their intimate partners (n = 92) were randomized to MB-CBCT
for PTSD and a control condition that teaches communication skills
drawn from the first seven sessions of the Couples Behavioural CT
manual. Formal publication of the study is pending at the time of
submission of this review. We contacted the authors for information
about the study methodology and conduct and expect to include
the results in the updated version of this review.
Primary outcome measures
1. Clinician-Administered PTSD Scale (CAPS)
Secondary outcomes measures
1. PTSD Checklist (PCL) self-report, veteran only
2. Dyadic Adjustment Scale (DAS) self-report, veteran and partner
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3. Beck Depression Inventory II (BDI) self-report, veteran and
partner
4. State-Trait Anxiety Inventory State Subscale (STAI-S) self-report,
veteran and partner
2. UCLA Welcome Back Veterans Family Resilience Center Couples
Counseling for Combat Veterans
This trial protocol (NCT01627548) for a pilot study was identified
in the initial search, and while it reports PTSD as an inclusion
criteria, the protocol uses couple's communication as the only
study outcome (rather than PTSD or other mental health measures).
The trial was registered on ClinicalTrials.gov in June 2012 and the
protocol contains a very limited amount of information about the
intended methodology with no results published on the website
or elsewhere. We contacted the authors for more information but
could not access any unpublished information.
3. Individual PE vs couples' CBT for combat-related post-traumatic
stress disorder
This clinical trial commenced in 2011 with data collection
reportedly finalised in August 2016 (NCT02336971). The study has
64 couples enrolled in which one of the members is a combat-
veteran with PTSD. Each couple has been randomised into one
of two cognitive-behavioural therapies developed specifically as a
treatment for PTSD - either prolonged exposure (PE) or cognitive-
behavioural couples therapy (CBCT). We contacted the authors for
more information and they confirmed that the study is completed
and is currently in manuscript writing phase. The main outcome
measures are as follows.
Primary outcome measures
1. PTSD symptoms, as measured by the CAPS and PCL at post-
treatment (approximately 12 weeks).
Secondary outcome measures
1. PTSD symptoms, as measured by the CAPS and PCL at 3-month,
6-month and 12-month follow-up.
2. Relationship outcomes, as measured by the Couples
Satisfaction Index at post-treatment (approximately 12 weeks),
and 3-month, 6-month and 12-month follow-up.
Risk of bias in included studies
For details of the risk of bias judgements for each study, see
Characteristics of included studies. A graphical representation of
the overall risk of bias in included studies is presented in Figure 2
and Figure 3.
 
Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 3.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
 
Allocation
Only Monson 2012 reported that the randomisation sequence was
adequately concealed and both Glynn 1999 and Monson 2012
reported the randomisation method used in their studies; thus we
classified Monson 2012 at low risk and Glynn 1999 at high risk
of selection bias. Selection bias was unclear for Sautter 2015 and
Ahmady 2009.
Blinding
None of the studies reported blinding of therapists and patients
(which is generally not feasible in studies of psychosocial
interventions), and thus we classified all at high risk of bias.
Outcome assessors were blinded in Monson 2012 and Glynn 1999,
but blinding was not reported in Sautter 2015 or Ahmady 2009; we
therefore classified them at unclear risk of bias. We considered all
self-report measures to produce a high risk of bias.
Incomplete outcome data
Completeness of the outcome data for each main outcome,
including attrition and exclusions from the analysis were reported
in Glynn 1999, Monson 2012 and Sautter 2015. While all 29 veterans
in both groups completed the DTE component of the trial in
Glynn 1999, of the 17 family units who were randomised to the
adjunctive condition, only 13 (76.5%) participated in the family
therapy component. Dropout reasons included changes in work
schedules (n = 2) and transportation problems (n = 2). From the
57 couples initially enrolled in Sautter 2015’s study, 43 (75.4%)
completed post-treatment assessments. Reasons for discontinuing
included relocation (n = 2), separation (n = 2), medical problems
(n = 1), domestic violence (n = 1) and in relation to eight couples,
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no reason was provided. From the 40 couples in Monson 2012's
study, 35 (87.5%) completed post-treatment assessments. Reasons
for dropping out included psychosis (n = 1), domestic violence (n =
1) and separation (n = 1), with no specific reasons given in relation
to two couples which dropped out.
Intention-to-treat (ITT) analyses were also reported in Monson 2012
and Sautter 2015 for all outcomes but no detailed ITT strategy
was included in the publications; we classified them at low risk
of incomplete outcome data. In the absence of ITT analyses, we
classified Glynn 1999 at high risk of attrition bias; and because
Ahmady 2009 did not report numbers of participants in relation to
the study outcomes, we classified it at unclear risk of attrition bias.
Selective reporting
Protocols were only available for Monson 2012 and Sautter 2015
and all pre-specified outcomes were reported for these studies. As
such, selective reporting bias was classified as low for both studies.
Glynn 1999 and Ahmady 2009 were not associated with published
protocols and were thus classified as unclear risk of bias.
Other potential sources of bias
There were no other obvious bias in the four studies included in
the review. Glynn 1999, Monson 2012 and Sautter 2015 provided
funding sources and no conflict of interests were declared (or
detected) in relation to any of the trials according to the information
reported.
E;ects of interventions
See: Summary of findings for the main comparison Stand-alone
couple or family therapy compared to no treatment for post-
traumatic stress disorder (PTSD); Summary of findings 2 Stand-
alone couple or family therapy compared to other structured or
non-specific intervention for post-traumatic stress disorder (PTSD);
Summary of findings 3 Adjunctive couple or family therapy
compared to structured or non-specific individual therapy alone for
post-traumatic stress disorder (PTSD)
Comparison 1: stand-alone couple or family therapy versus no
treatment
Two studies including 100 couples (200 participants) contributed
data to this comparison (Ahmady 2009; Monson 2012). See also:
Summary of findings for the main comparison.
1.1 Severity of PTSD symptoms
Data on PTSD severity from one study of 40 couples (n = 80
participants) produced an overall eGect for CBCT, relative to the
wait-list control, which was significantly diGerent from zero (SMD
−1.12, 95% CI −1.79 to −0.45; Analysis 1.1) (Monson 2012). The point
estimate for the SMD indicated a large eGect and potential benefit
of CBCT. Given that only one study was available, it was not possible
to appraise statistical heterogeneity for the analyses.
1.2 Dyadic adjustment
Data on dyadic adjustment as reported by the primary participant
and their partner across two studies involving 100 couples (200
participants) produced an overall eGect for CBCT, relative to the
wait-list control, that was not significantly diGerent from zero (SMD
1.07, 95% CI −0.17 to 2.31; I2 = 88%; Analysis 1.2) (Ahmady 2009;
Monson 2012). Although the point estimate for the SMD suggested a
very large eGect and potential benefit of the intervention, the wide
confidence interval indicates high levels of imprecision. The largest
eGect was derived from one study which did not report group
means at post treatment, but rather reported the mean diGerence
between pre- and post-intervention for both intervention and
control groups, which we thus used for purposes of analysis
(Ahmady 2009).
1.3 Family member severity of depression
Data on partners’ depressive symptoms from one study of 40
couples (80 participants) produced an overall eGect for CBCT,
relative to the wait-list control, which was not significantly diGerent
from zero (SMD 0.28, 95% CI −0.35 to 0.90; Analysis 1.3) (Monson
2012). The point estimate for the SMD suggested a small eGect
and potential benefit of wait-list condition although the confidence
interval indicates high levels of imprecision. Given that only one
study was available, it was not possible to appraise statistical
heterogeneity for the analysis.
1.4 Family member severity of anxiety
Data on partners’ anxiety symptoms from one study of 40 couples
(80 participants) produced an overall eGect for CBCT, relative to
the wait-list control, which was not significantly diGerent from zero
(SMD 0.15, 95% CI −0.47 to 0.77; Analysis 1.4) (Monson 2012). The
point estimate for the SMD suggested a small eGect and potential
benefit of wait-list condition, although the wide confidence interval
indicates high levels of imprecision. Given that only one study was
available, it was not possible to appraise statistical heterogeneity
for the analysis.
1.5 Severity of depression for the person with PTSD
Data on the severity of depression for the primary participant with
PTSD from one study of 40 couples (80 participants) produced
an overall eGect of CBCT, relative to the wait-list control, which
was significantly diGerent from zero (SMD −0.66, 95% CI −1.30 to
−0.02; Analysis 1.5) (Monson 2012). The point estimate for the SMD
indicated a moderate to large eGect and potential benefit of CBCT.
Given that only one study was available, it was not possible to
appraise statistical heterogeneity for the analysis.
1.6 Severity of anxiety for the person with PTSD
Data on the severity of anxiety for the primary participants with
PTSD from one study of 40 couples (80 participants) produced
an overall eGect of CBCT, relative to the wait-list control, that
was significantly diGerent from zero (SMD −0.93, 95% CI −1.58
to −0.27; Analysis 1.6) (Monson 2012). The point estimate for the
SMD indicated a large eGect and potential benefit of CBCT. Given
that only one study was available, it was not possible to appraise
statistical heterogeneity for the analysis.
1.7 Family functioning
There were no studies of a stand-alone couple or family therapy for
PTSD versus no treatment which provided data on this outcome.
1.8 Treatment dropout
Data on treatment dropout from one study of 40 couples (80
participants) showed no significant diGerence between CBCT and
wait-list control conditions (OR 0.41, 95% CI 0.09 to 1.95; Analysis
1.7) (Monson 2012). The point estimate for the OR suggested
a small eGect and lower rates of dropout for wait-list control
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condition, although the confidence interval suggested high levels
of imprecision.
Comparison 2: stand-alone couple or family therapy versus
standard care
There were no eligible studies that compared couple or family
therapies for PTSD to standard care or a 'treatment as usual'
conditions.
Comparison 3: stand-alone couple or family therapy versus
other structured or non-specific intervention
One study with 57 couples (114 participants) contributed data to
this comparison (Sautter 2015). See also: Summary of findings for
the main comparison. Given that only one study was available, it
was not possible to appraise statistical heterogeneity for any of the
analyses situated under this comparison.
3.1 Severity of PTSD symptoms
Data on PTSD severity from one study of 57 couples (114
participants) produced an overall eGect for SAT, relative to PFE, that
was significantly diGerent from zero (SMD −1.32, 95% CI −1.90 to
−0.74; Analysis 2.1) (Sautter 2015). The point estimate for the SMD
indicated a very large eGect and potential benefit of SAT.
3.2 Dyadic adjustment
Data on dyadic adjustment from one study of 57 couples (114
participants) produced an overall eGect for SAT, relative to PFE (SMD
0.01, 95% CI −0.51 to 0.53; Analysis 2.2) (Sautter 2015) with the
confidence interval indicating high levels of imprecision.
3.3 Family member severity of depression
Data on partners’ depression symptoms from one study of 57
couples (114 participants) produced an overall eGect for the SAT,
relative to PFE, that was not significantly diGerent from zero (SMD
0.21, 95% CI −0.31 to 0.73; Analysis 2.3) (Sautter 2015). The point
estimate for the SMD suggested a small eGect and potential benefit
of PFE, although the confidence interval indicates high levels of
imprecision.
3.4 Family member severity of anxiety
Data on partners’ anxiety symptoms from one study of 57 couples
(114 participants) produced an overall eGect for the SAT, relative
to PFE, that was not significantly diGerent from zero (SMD −0.16,
95% CI −0.68 to 0.36; Analysis 2.4) (Sautter 2015). The point estimate
for the SMD suggested a small eGect and potential benefit of PFE,
although the confidence interval suggested that zero eGect was
also plausible.
3.5 Severity of depression for the person with PTSD
Data on the severity of depression for the primary patient with PTSD
from one study of 57 couples (114 participants) produced an overall
eGect of SAT, relative to PFE, that was not significantly diGerent
from zero (SMD −0.28, 95% CI −0.81 to 0.24; Analysis 2.5) (Sautter
2015). The point estimate for the SMD indicated a small eGect and
potential benefit of SAT, although the confidence interval indicates
high levels of imprecision.
3.6 Severity of anxiety for the person with PTSD
Data on the severity of anxiety for the primary patient with PTSD
from one study of 57 couples (114 participants) produced an overall
eGect for SAT, relative to PFE, that was not significantly diGerent
from zero (SMD −0.34, 95% CI −0.87 to 0.18; Analysis 2.6) (Sautter
2015). The point estimate for the SMD indicated a small eGect and
potential benefit of SAT, although the confidence interval indicates
high levels of imprecision.
3.7 Family functioning
The one eligible study which was organised under this comparison
did not evaluate overall family functioning and no analyses could
be conducted for this outcome.
3.8 Treatment dropout
Data on treatment dropout from one study of 57 couples (114
participants) showed no significant diGerence between SAT and
PFE conditions (OR 0.95, 95% CI 0.29 to 3.19; Analysis 2.7) (Sautter
2015). The point estimate for the OR suggested a small eGect and
lower rates of dropout for wait-list control condition, although the
confidence interval indicates high levels of imprecision.
Comparison 4: adjunctive couple or family therapy versus
standard care
There were no eligible studies that compared adjunctive couple or
family therapies to standard care or 'treatment as usual' conditions.
Comparison 5: adjunctive couple or family therapy versus
structured or non-specific individual therapy alone
There was one eligible study of 29 family-dyads (58 participants)
under this comparison (Glynn 1999). However, the study did not
report any relevant post-treatment data (Means and SDs) for the
outcomes and we could not include them in the meta-analyses.
The main report on this study describes three outcomes at post-
treatment: (1) a social adjustment score (SAS), reported by the
primary patient with PTSD; (2) a composite score for PTSD-positive
symptoms using scores derived from three diGerent scales (M-
PTSD, CAPS, IOE); and (3) a composite score on PTSD-negative
symptoms using scores derived from these three scales (M-PTSD,
CAPS, IOE). We could not retrieve the actual scale scores for PTSD
symptom severity on the basis of the information provided by
the authors (published and unpublished data). The study authors
concluded that there were no statistically significant diGerences
between the DTE and DTE plus behavioural family therapy (BFT)
conditions on positive or negative PTSD symptomatology or social
adjustment. Of the outcomes specified in this review, Glynn 1999
provided data on treatment dropout only.
5.1 Treatment dropout
Data on treatment dropout from Glynn 1999 of 29 family units (58
participants) showed a significant diGerence between DTE and the
adjunct treatment (DTE + BFT) conditions (OR 14.13, 95% CI 0.71
to 279.83; Analysis 3.1). The point estimate for the OR suggested a
large eGect with lower rates of dropout for DTE condition. However,
the confidence interval for this comparison was extremely wide
suggesting high levels of imprecision.
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Subgroup analyses
There was an insuGicient number of studies available to conduct
subgroup analyses for the current version of the review.
Sensitivity analyses
We were only able to conduct a small selection of the planned
sensitivity analyses.
Outcome data from multiple informants were excluded for Monson
2012 and Sautter 2015. We ran sensitivity analyses for Comparisons
1 and 3 for dyadic adjustment excluding the partner data. The
Monson 2012 study showed an overall eGect for the CBCT group,
relative to the wait list condition, that was significantly diGerent
from zero (SMD 0.65, 95% CI 0.01 to 1.29). In Sautter 2015, aIer
excluding the partner responses, there were no diGerences in
dyadic adjustment, reported by the persons with PTSD, between
the intervention group and the active comparator (SMD 0.16, 95%
CI −0.36 to 0.68).
We were not able to address sensitivity analyses as planned for
cluster randomised trials (excluding cluster randomised trials or
varying the ICC during analyses) as there were none identified in
this review. Similarly, we were not able to complete sensitivity
analyses excluding cross-over trials as none were identified.
Sensitivity analyses excluding imputed values or including
'completers only' were not performed as this data was not available
in the studies in this review.
Reporting bias
We detected no reporting bias in relation to the two studies as
reported in Selective reporting (reporting bias).
D I S C U S S I O N
Summary of main results
The main aim of this review was to identify and synthesise
evidence for the eGects of couple and family therapies for PTSD.
A comprehensive systematic search identified four RCTs (involving
186 couples/family units and 372 individuals) that were eligible
for the review, although there were only two of these studies that
provided suGicient data for analyses across a range of outcomes.
These data supported analyses under three diGerent comparisons:
(1) stand-alone couple or family therapy versus no treatment;
(2) stand-alone couple or family therapy versus other structured
or non-specific intervention; and (3) adjunctive couple or family
therapy versus structured or non-specific individual therapy alone.
It is important to note that while the studies used diGerent names
for the trialled family interventions (CBCT, BFT, SAT), the content
and organisation of these interventions were highly similar.
The results from analyses under Comparison 1 and 2 indicated
that stand-alone couples' interventions based largely on cognitive-
behavioural principles were associated with some potential
improvements in individual PTSD symptoms for the primary
presenting patient, as well as their other mental health problems.
In contrast, however, there was limited evidence of parallel
improvements in reports of dyadic adjustment or the psychological
problems of intimate partners. The only analyses possible under
Comparison 3 addressed treatment dropout and there was little
evidence pertaining to the potential benefits of couple or family
therapies when utilised as an adjunct to individual PTSD treatment.
We viewed dropout rate as a proxy measure of treatment
acceptability in this review, and with 65% of family units completing
the post-treatment measures for the family therapy condition,
we concluded that the treatment acceptability for the adjunct
intervention was moderate to low.
There were no eligible trials and thus evidence which considered
other types of couple or family therapies, including those which
are based on psychodynamic or systems-based theories or clinical
approaches. Although there was substantial variability across
studies in terms of risk of bias, there was a downgrade in certainty
(we graded the overall evidence as low or very low-quality) given
the small amount of evidence currently available.
Overall completeness and applicability of evidence
The included studies suggested that couple and family therapies
produced meaningful improvements in individual symptoms for
the primary presenting patient with PTSD, while there was
limited evidence of change in dyadic adjustment of psychological
problems for intimate partners. These conclusions were based,
however, on a comprehensive search which identified only four
RCTs, and only two of these provided data across multiple
outcomes that were suGicient for analysis. There were therefore
very few relevant studies in an absolute sense, and thus limited
evidence overall which indicates the presence of absence of
benefits for individuals or family members from couple or family
therapies for PTSD.
The two main studies which we analysed both considered
ostensibly similar disorder-specific and stand-alone therapies
(although compared to diGerent control conditions), which were
based on cognitive-behavioural principles and addressed similar
target populations and contexts; that is, war veterans (mainly) with
PTSD and their partners attending veterans’ mental health services.
Therefore the available findings relate primarily to PTSD symptoms
and family problems which are linked (presumably) to military
experiences, and there is limited applicability to other forms of
trauma, such as exposure to violence or abuse, natural disasters or
physical injuries.
The review identified only one trial which considered a
behaviourally focused family-based therapy that was adjunctive to
individualised treatment, and this study did not report suGicient
information to address the primary aims of this review. Thus it
remains unclear whether couple- or family-based therapies have
beneficial eGects on PTSD or related interpersonal problems when
integrated with a programme of individual treatment. This is
notwithstanding that the inclusion of family members in treatment
has been included in the treatment guidelines for PTSD for well over
a decade (Foa 2008).
In contrast, there were no randomised trials of other types of
couple or family therapies, including those which are based on
alternative theoretical models (e.g. psychodynamic theory), and
there is little evidence to illustrate the potential eGects of these
interventions. These include interventions based on family systems
theory, such as Strategic Family Therapy (Minuchin 1974), which
could foreseeably have stronger eGects on dyadic adjustment and
the psychological problems of intimate partners. There is also no
evidence available from comparative studies to indicate whether
diGerent types of couple- or family-based therapies may be more
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or less helpful in the treatment of PTSD and associated family
problems.
Quality of the evidence
Overall, the evidence was of low to very low-quality as measured
by the GRADE framework. This primarily reflected a downgrade
in certainty given the small number of available studies. That is,
there were only four trials that were eligible for this review, and
only two reported data across multiple outcomes (including PTSD
symptom severity for the primary patient) that were suGicient
for analyses. Furthermore, these two trials involved comparisons
with diGerent control conditions, and could not be integrated
in the same analyses that could formally appraise the statistical
heterogeneity of findings.
While one of the eligible studies received classifications of low
risk of bias on most metrics (which the exception of blinding of
participants and personnel, which is unsurprising for clinical trials
of psychosocial interventions) (Monson 2012), the limited amount
of evidence necessarily required that certainty was downgraded
to low or very low across analyses. The two studies which did not
report suGicient data for analyses across most outcomes were also
classified as high or unclear risk of bias according to most metrics.
Potential biases in the review process
We searched thoroughly all relevant outlets and strictly adhered to
the protocol in the process of study identification, selection, data
extraction and entry, and analysis. We only considered published
studies, which may perpetuate publication biases. We found
registered protocols for two reportedly completed studies that
were missing a peer-reviewed outcome publication (NCT01035788;
NCT02336971a): this may be indicative of high publication bias,
given the small number of studies available overall. We also note
that it was a limitation of the review that some potential outcomes
were not included in the protocol including suicidality, sexual
functioning and sexual satisfaction. While these were not measured
in any of the included studies, we may consider a wider range of
family-level outcomes in the updates of the review.
Agreements and disagreements with other studies or
reviews
To our knowledge, there are no other reviews of couples’ and
family therapy for PTSD. Other relevant reviews have examined
individually focused therapies for PTSD in the context of both adult
(Bisson 2013) and child or adolescent populations (Gillies 2016),
and interventions focused on the prevention of PTSD (Roberts
2009). These have generally concluded that treatments based on
cognitive behavioural principles are eGicacious when compared to
control conditions, and such findings are consistent with outcomes
of the current review which were also based mainly on studies
of cognitive-behavioural therapies delivered using a couple-based
format. The eGect sizes from our review were slightly smaller than
those reported for individually oriented psychological therapies for
adult PTSD (Bisson 2013), although any such comparisons should
be viewed cautiously given the small number of studies, and thus
the lack of precision of point estimates in this review.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
The available evidence, while modest in quantity and low in quality,
points to some potential benefits of disorder-specific treatments
for couples which are based on cognitive behavioural principles
and aim mainly to improve individual PTSD symptoms. Against our
expectations, however, the benefits were not as clear for improving
relationship quality or the mental health of family members,
which are also negatively impacted by PTSD. These interpersonal
problems and consequences of PTSD are arguably where couple
or family interventions should have particular benefit, and thus
the absence of preliminary support for such eGects might raise
questions about the unique value of couple interventions, relative
to individual treatments that have a stronger evidence base.
However, as noted previously, there were few studies in this
review which also examined a homogenous collection of cognitive-
behavioural treatments, and these did not consider a range of
alternative intervention models (e.g. based on family systems
theory; Minuchin 1974) which might have stronger dyadic or
interpersonal benefits.
Given the lack of studies comparing couple and family therapies
to individually-based or other structured treatments, there is
insuGicient evidence to indicate whether couple-based approaches
oGer benefit over other types of intervention. There is also
insuGicient evidence to determine whether there are any
meaningful diGerences in the eGects of diGerent types of couple and
family therapies (including generic versus disorder-specific couple
or family therapies).
Even though family therapy is included in the treatment guidelines
for PTSD, the current review does not yet support a strong evidence-
based rationale for including couple or family therapy components
in the standard treatment for PTSD, either as adjunctive or stand-
alone intervention. While there is preliminary evidence that couple-
based approaches could be beneficial for the individual patient,
clinicians working with clients who suGer PTSD should adopt
cautious approaches to working with couples that is based on
clinical judgement, rather than strong empirical evidence. Some
of the included studies outlined risk of Intimate Partner Violence
(IPV) during treatment and this warrants careful monitoring of
the safety and well-being of family members. In addition to the
risk of ongoing IPV in families, other reasons to preclude family
members from the treatment for PTSD include family members'
own mental health problems, such as their own PTSD, or misuse of
substances. A thorough assessment process before the inclusion of
family/couple therapy for PTSD is recommended, involving clinical
interviews with relevant family member(s), with a strong emphasis
on patient preferences in treatment planning. Clinicians who
deliver trauma-focused therapies should be trained and educated
about all potential benefits and limitations of family and couple-
based treatments for PTSD.
Implications for research
The review identified potential benefits of couples-based therapies
for PTSD, but few relevant studies, and it thus indicates a strong
need for additional trials. These should involve samples which
are large enough to detect eGects which are small to moderate
in magnitude, and define the eGects of interventions in terms
of individual PTSD symptoms, as well as measures of overall
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family well-being or functioning and other relational outcomes (e.g.
family member mental health, relationship satisfaction) that are
negatively impacted by PTSD.
Given the potentially unique contribution of couple and family
therapies to improving relational outcomes, there is a particular
need for trials of couple and family therapies which are adjunctive
to individual PTSD treatment. These adjunctive components
should be carefully developed using co-design methodologies in
order to maximise acceptability, and involve PTSD clients, family
members, and service providers and clinicians. Future trials should
also involve rigorous and transparent implementation guidelines
and fidelity assessment to locate the potential pitfalls of including
a family component in the course of treatment for PTSD.
The studies in this review focused mainly on samples aGected
by military or combat-related trauma, and future trials should
examine the eGects of couple or family therapies in the context
of other types of trauma. These might include, for example,
traumatic stress linked to grief and bereavement, child abuse, and
diverse types of violence (victims of crime, torture). It may be
that couple and family therapies have variable eGects according
to diGerent types of trauma exposure, such as those which have
a major interpersonal dimension (e.g. interpersonal violence).
Again, careful planning and co-design of interventions with trauma-
aGected individuals should inform the development of therapy
components.
While treatments based on cognitive behavioural principles are
known to benefit individual and family well-being in a number
of settings (e.g. Pavuluri 2004; Wood 2006), the eGects of other
treatment models for families and partners of PTSD suGerers
should be further explored. Comparative trials of diGerent types
of couple or family therapies could also help illustrate the relative
benefits of these approaches to intervention. For example, while no
emotionally focused therapies (EFT) were included in the review,
EFT has been suggested as particularly beneficial for the treatment
of PTSD in a relational or family context (e.g. Blow 2015) and we
hope to include new trials of EFT-based modalities in subsequent
updates to this review.
A C K N O W L E D G E M E N T S
We would like to acknowledge the ongoing and rigorous support of
the Cochrane Common Mental Disorders Group, and in particular
Sarah Dawson, Jessica Hendon, Jessica Sharp and Chris Cooper.
The authors and the Cochrane Common Mental Disorders Editorial
Team are grateful to the peer reviewers for their time and
comments including: Brian Duncan, David Marshall, Sujoy Ray and
Lindsay Robertson. They would also like to thank Cochrane Copy
Edit Support for the team's help.
CRG funding acknowledgement: the National Institute for Health
Research (NIHR) is the largest single funder of the CCMD Group.
Disclaimer: the views and opinions expressed herein are those of
the review authors and do not necessarily reflect those of the NIHR,
the NHS or the Department of Health and Social Care.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
R E F E R E N C E S
 
References to studies included in this review
Ahmady 2009 {published data only (unpublished sought but not
used)}
Ahmady K, Karami G, Noohi S, Mokhtari A, Gholampour H,
Rahimi AA. The eGicacy of cognitive behavioral couple’s therapy
(CBCT) on marital adjustment of PTSD–diagnosed combat
veterans. Europe’s Journal of Psychology 2009;5(2):31-40.
Glynn 1999 {published data only (unpublished sought but not
used)}
* Glynn SM, Eth S, Randolph ET, Roy DW, Urbaitis M, Boxer L, et
al. A test of behavioural family therapy to augment exposure
for combat-related post-traumatic stress disorder. Journal of
Consulting and Clinical Psychology 1999;67(2):243-51.
Monson 2012 {published data only}
Monson CM, Fredman SJ, MacDonald A, Pukay-Martin ND,
Resick PA, Schnurr PP. EGect of cognitive-behavioural couple
therapy for PTSD. JAMA 2012;308(7):700-9.
Sautter 2015 {published data only}
Sautter FJ, Glynn SM, Becker-Cretu JJ, Senturk, D, Armelie AP,
Wielt DB. Structured approach therapy for combat-related
PTSD in returning U.S. veterans: Complementary mediation by
changes in emotion functioning. Journal of Traumatic Stress
2016;29(4):384-7.
Sautter FJ, Glynn SM, Cretu JB, Senturk D, Vaught AS. EGicacy
of a structured approach therapy in reducing PTSD in returning
veterans: A randomized clinical trial. Psychological Services
2015;12(3):199-212.
 
References to studies excluded from this review
Cahoon 1984 {published data only}
Cahoon EP. An examination of relationships between post-
traumatic stress disorder, marital distress, and response
to therapy by Vietnam veterans (couples groups, rap
group therapy) [PhD thesis]. Ann Arbor (USA): University of
Connecticut 1984.
Heinrichs 2012 {published data only}
Heinrichs N, Zimmermann T, Huber B, Herschbach P,
Russell DW, Baucom DH. Cancer distress reduction with a
couple-based skills training: a randomized controlled trial.
Annals of behavioral medicine : a publication of the Society
of Behavioral Medicine 2012;43(2):239-252. [DOI: 10.1007/
s12160-011-9314-9]
Holditch-Davis 2014 {published data only}
Holditch-Davis D, White-Traut RC, Levy JA, O'Shea TM,
Geraldo V, David RJ. Maternally administered interventions for
preterm infants in the NICU: EGects on maternal psychological
distress and mother-infant relationship. Infant Behavior &
Development 2014;37:695-710. [DOI: http://dx.doi.org/10.1016/
j.infbeh.2014.08.005]
Jones 2004 {published data only}
Jones C, Skirrow P, GriGiths RD, Humphris G, Ingleby S,
Eddleston J, Waldmann C, Gager M. Post-traumatic stress
disorder-related symptoms in relatives of patients following
intensive care. Intensive Care Medicine 2004;30:456-460.
Jones 2012 {published data only}
Jones C, Backman C, GriGiths RD. Intensive care diaries and
relatives' symptoms of posttraumatic stress disorder aIer
critical illness: a pilot study. American Journal of Critical Care
2012;21:172-176.
Kersting 2013 {published data only}
Kersting A, Dolemeyer R, Steinig J, Walter F, Kroker K,
Baust K, Wagner B. Brief internet-based intervention reduces
posttraumatic stress and prolonged grief in parents aIer the
loss of a child during pregnancy: A randomized controlled trial.
Psychotherapy and Psychosomatics 2013;82:372-381.
King 2000 {published data only}
King NJ, Tonge BJ, Mullen P, Myerson N, Heyne D, Rollings S,
Martin R, Ollendick TH. Treating sexually abused children
with posttraumatic stress symptoms: A randomized
clinical trial. Journal of the American Academy of Child
and Adolescent Psychiatry 2000;39:1347-1355. [DOI:
10.1097/00004583-200011000-00008]
Knox 2016 {published data only}
Knox MR. The eGectiveness of EFT combined with EMDR
for military couples [PhD thesis]. Ann Arbor (USA): Regent
University 2016.
Landy 2015 {published data only}
Landy MSH, Pukay-Martin ND, Vorstenborch V, Torbit L,
Monson CM. A pilot study of the eGects of cognitive-
behavioral conjoint therapy for posttraumatic
stress disorder on parenting. Journal of Aggression,
Maltreatment and Trauma 2015;24:454-465. [DOI: http://
dx.doi.org/10.1080/10926771.2015.1022678]
Zimmermann 2016 {published data only}
Zimmermann T, Heinrichs N. Couples coping with cancer: A
couples-based skills intervention for breast cancer patients and
their partners. Psycho-Oncology 2016;25:172-172.
 
References to studies awaiting assessment
NCT01035788 {unpublished data only}
NCT01035788. EGects of mindfulness-based cognitive-
behavioral conjoint therapy on PTSD and relationship function.
clinicaltrials.gov/ct2/show/NCT01035788 (first received 21
December 2009).
NCT01627548 {published data only}
NCT01627548. UCLA Welcome Back Veterans Family
Resilience Center Couples Counseling for Combat
Veterans. clinicaltrials.gov/ct2/show/NCT01627548?
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
term=NCT01627548&draw=2&rank=1 (first received 25 June
2012).
NCT02336971 {unpublished data only}
NCT02336971. Individual prolonged exposure (PE) versus
couples' cognitive-behavioral therapy for combat-related
posttraumatic stress disorder (PTSD). clinicaltrials.gov/ct2/
show/NCT02336971 (first received 13 January 2015).
 
References to ongoing studies
NCT02720016 {published data only}
NCT02720016. An Integrative Technology Approach to Home-
based Conjoint Therapy for PTSD. clinicaltrials.gov/ct2/show/
NCT02720016 (first received 25 March 2016).
 
Additional references
American Psychiatric Association 2000
American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV). Text Revision. Fourth.
Washington, DC: American Psychiatric Association, 2000.
American Psychiatric Association 2013
American Psychiatric Association. Diagnostic and Statistical




Amos T, Stein DJ, Ipser JC. Pharmacological interventions
for preventing post-traumatic stress disorder (PTSD).
Cochrane Database of Systematic Reviews 2014, Issue 7. [DOI:
10.1002/14651858.CD006239.pub2]
Atwoli 2015
Atwoli S, Stein DJ, Koenen KC, McLaughlin KA. Epidemiology
of posttraumatic stress disorder: prevalence, correlates and
consequences. Current Opinion in Psychiatry 2015;28(4):307-11.
Balshem 2011
Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R,
Brozek J, et al. GRADE guidelines: 3. Rating the quality of
evidence. Journal of Clinical Epidemiology 2011;64(4):401-6.
Baucom 1998
Baucom DH, Shoham V, Mueser KT, Daiuto AD, Stickle TR.
Empirically supported couple and family interventions for
marital distress and adult mental health problems. Journal of
Consulting and Clinical Psychology 1998;66(1):53-88.
Beck 1961
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An
inventory for measuring depression. Archives of General
Psychiatry 1961;4(6):561-71.
Beck 1988
Beck AT, Epstein N, Brown G, Steer RA. An inventory for
measuring clinical anxiety: Psychometric properties. Journal of
Consulting and Clinical Psychology 1988;56(6):893-7.
Bisson 2007
Bisson J, Andrew M. Psychological treatment of post-traumatic
stress disorder (PTSD). Cochrane Database of Systematic
Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003388.pub3]
Bisson 2013
Bisson JI, Roberts NP, Andrew M, Cooper R,
Lewis C. Psychological therapies for chronic post-
traumatic stress disorder (PTSD) in adults. Cochrane
Database of Systematic Reviews 2013, Issue 12. [DOI:
10.1002/14651858.CD003388.pub4]
Blake 1995
Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD,
Charney DS, et al. The development of a clinician-administered
PTSD scale. Journal of Traumatic Stress 1995;8(1):75-90.
Blow 2015
Blow AJ, Curtis AF, Wittenborn AK, Gorman L. Relationship
problems and military-related PTSD: the case for using
emotionally focused therapy for couples. Contemporary Family
Therapy 2015;37(3):261-70. [DOI: 10.1007/s10591-015-9345-7]
Brown-Bowers 2012
Brown-Bowers A, Fredman SJ, Wanklyn SG, Monson CM.
Cognitive-behavioral conjoint therapy for posttraumatic
stress disorder: Applications to a couple's shared traumatic
experience. Journal of Clinical Psychology 2012;68(5):536-47.
Christensen 2004
Christensen A, Atkins DC, Berns S, Wheeler J, Baucom DH,
Simpson LE. Traditional versus integrative behavioral couple
therapy for significantly and chronically distressed married
couples. Journal of Consulting and Clinical Psychology
2004;72(2):176-91.
Cloitre 1997
Cloitre M, Scarvalone P, Difede J. Posttraumatic stress
disorder, self- and interpersonal dysfunction among
sexually retraumatized women. Journal of Traumatic Stress
1997;10(3):437-52.
Coulter 2013
Coulter S. Systemic psychotherapy as an intervention for
post-traumatic stress responses: an introduction, theoretical
rationale and overview of developments in an emerging field of
interest. Journal of Family Therapy 2013;35(4):381-406.
Davis 2000
Davis JL, Petretic-Jackson PA. The impact of child sexual abuse
on adult interpersonal functioning: A review and synthesis
of the empirical literature. Aggression and Violent Behavior
2000;5(3):291-328.
Deeks 2011
Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing
data and undertaking meta-analyses. In: Higgins JPT, Green
S (editors). Cochrane Handbook for Systematic Reviews of
Interventions Version 5.1.0 (updated March 2011). The Cochrane
Collaboration, 2011. Available from handbook.cochrane.org.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
Dirkzwager 2003
Dirkzwager AJE, Bramsen I, van der Ploeg HM. Social support,
coping, life events, and posttraumatic stress symptoms among
former peacekeepers: A prospective study. Personality and
Individual Di:erences 2003;34(8):1545-59.
Egger 1997
Egger M, Davey Smith G, Minder C. Bias in meta-
analysis detected by a simple, graphical test. BMJ
1997;315(7109):629-34.
Epstein 1983
Epstein NB, Baldwin LM, Bishop DS. The McMaster Family
Assessment Device. Journal of Marital and Family Therapy
1983;9(2):171-80.
Erbes 2008
Erbes CR, Polusny MA, MacDermin S, Compton JS. Couple
therapy with combat veterans and their partners. Journal of
Clinical Psychology 2008;64(8):972-83.
Evans 2009
Evans L, Cowlishaw S, Hopwood M. Family functioning predicts
outcomes for veterans in treatment for chronic posttraumatic
stress disorder. Journal of Family Psychology 2009;23(4):531-9.
Evans 2010
Evans L, Cowlishaw S, Forbes D, Parslow R, Lewis V.
Longitudinal analyses of family functioning in veterans and
their partners across treatment. Journal of Consulting and
Clinical Psychology 2010;78(5):611-22.
Figley 1988
Figley CR. A five-phase treatment of post-traumatic
stress disorder in families. Journal of Traumatic Stress
1988;1(1):127-41.
Foa 1993
Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and
validity of a brief instrument for assessing post-traumatic stress
disorder. Journal of Traumatic Stress 1993;6(4):459-73.
Foa 2008
Foa FB, Keane TM, Friedman MJ, Cohen JA. EGective treatments
for PTSD: Practice guidelines from the International Society for
Traumatic Stress Studies. Guilford Press, 2008.
Fowers 1993
Fowers BJ, Olson, DG. ENRICH Marital Satisfaction Scale: A
brief research and clinical tool. Journal of Family Psychology
1993;7(2):176-185.
Frasure-Smith 2000
Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M,
Talajic M, et al. Social support, depression, and mortality
during the first year aIer myocardial infarction. Circulation
2000;101(16):1919-24.
Freedland 2011
Freedland KE, Mohr DC, Davidson KW, Schwartz JE. Usual and
unusual care: Existing practice control groups in randomized
controlled trials of behavioral interventions. Psychosomatic
Medicine 2011;73(4):323-35.
Friedman 2011
Friedman MJ, Resick PA, Bryant RA, Brewin CR. Considering
PTSD for DSM-5. Depression and Anxiety 2011;28(9):750-69.
Galovski 2004
Galovski T, Lyons JA. Psychological sequelae of combat
violence: A review of the impact of PTSD on the veteran's family
and possible interventions. Aggression and Violent Behavior
2004;9(5):477-501.
Gillies 2012
Gillies D, Taylor F, Gray C, O'Brien L, D'Abrew N.
Psychological therapies for the treatment of post-traumatic
stress disorder in children and adolescents. Cochrane
Database of Systematic Reviews 2012, Issue 12. [DOI:
10.1002/14651858.CD006726.pub2]
Gillies 2016
Gillies D, Maiocchi L, Bhandari AP, Taylor F, Gray C, O'Brien L.
Psychological therapies for children and adolescents exposed
to trauma. Cochrane Database of Systematic Reviews 2016, Issue
10. [DOI: 10.1002/14651858.CD012371]
Glass 1992
Glass TA, Maddox GL. The quality and quantity of social
support: stroke recovery as psycho-social transition. Social
Science & Medicine 1992;34(11):1249-61.
Glenn 2002
Glenn DM, Beckham JC, Feldman ME, Kirby AC, Hertzberg MA,
Moore SD. Violence and hostility among families of Vietnam
veterans with combat-related posttraumatic stress disorder.
Violence and Victims 2002;17(4):473-89.
Go; 2007
GoG BS, Crow JR, Reisbig AM, Hamilton S. The impact
of individual trauma symptoms of deployed soldiers on
relationship satisfaction. Journal of Family Psychology
2007;21(3):344-53.
Graham 2009
Graham JW. Missing data analysis: Making it work in the real
world. Annual Review of Psychology 2009;60:549-79.
Hetrick 2010
Hetrick SE, Purcell R, Garner B, Parslow R. Combined
pharmacotherapy and psychological therapies for
post traumatic stress disorder (PTSD). Cochrane
Database of Systematic Reviews 2010, Issue 7. [DOI:
10.1002/14651858.CD007316.pub2]
Higgins 2011a
Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies
and collecting data. In: Higgins JPT, Green S (editors), Cochrane
Handbook for Systematic Reviews of Interventions Version
5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
Available from www.cochrane-handbook.org.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
Higgins 2011b
Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special
topics in statistics. In: Higgins JPT, Green S (editors), Cochrane
Handbook for Systematic Reviews of Interventions Version
5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
Available from www.cochrane-handbook.org.
Higgins 2017
Higgins JP, Altman DG, Sterne JA, (editors). Chapter 8: Assessing
risk of bias in included studies. In: Higgins JP, Churchill R,
Chandler J, Cumpston MS, editor(s), Cochrane Handbook for
Systematic Reviews of Interventions version 5.2.0 (updated
June 2017). The Cochrane Collaboration, 2017. Available from
www.training.cochrane.org/handbook.
Huedo-Medina 2006
Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J.
Assessing heterogeneity in meta-analysis: Q statistic or I2
index?. Psychological Methods 2006;11(2):193-206.
Hutton 2000
Hutton JL, Williamson PR. Bias in meta-analysis due to outcome
variable selection within studies. Journal of the Royal Statistical
Society. Series C, Applied Statistics 2000;49(3):359-70.
Johnson 1998
Johnson SM, Williams-Keeler L. Creating healing relationships
for couples dealing with trauma: the use of emotionally
focused marital therapy. Journal of Marital and Family Therapy
1998;24(1):25-40.
Jordan 1992
Jordan KB, Marmar CR, Fairbank JA, Schlenger WE, Kulka RA,
Hough RL, et al. Problems in families of male Vietnam veterans
with posttraumatic stress disorder. Journal of Consulting and
Clinical Psychology 1992;60(6):916-26.
Juni 1999
Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring
the quality of clinical trials for meta-analysis. Journal of the
American Medical Association 1999;282(11):1054-60.
Kaniasty 2008
Kaniasty K, Norris FH. Longitudinal linkages between perceived
social support and posttraumatic stress symptoms: sequential
roles of social causation and social selection. Journal of
Traumatic Stress 2008;21(3):274-81.
Krause 2006
Krause ED, Kaltman S, Goodman L, Dutton MA. Role of distinct
PTSD symptoms in intimate partner reabuse: a prospective
study. Journal of Traumatic Stress 2006;19(4):507-16.
Lamoureux 2012
Lamoureux BE, Palmieri PA, Jackson AP, Hobfoll SE. Child sexual
abuse and adulthood-interpersonal outcomes: examining
pathways for intervention. Psychological Trauma : Theory,
Research, Practice and Policy 2012;4(6):605-13.
Laurenceau 1998
Laurenceau J, Barrett LF, Pietromonaco PR. Intimacy as an
interpersonal process: the importance of self-disclosure,
partner disclosure, and perceived partner responsiveness in
interpersonal exchanges. Journal of Personality and Social
Psychology 1998;74(5):1238-51.
Lebow 1997
Lebow J. The integrative revolution in couple and family
therapy. Family Process 1997;36(1):1-17.
Lebow 2012
Lebow JL, Chambers AL, Christensen A, Johnson SM. Research
on the treatment of couple distress. Journal of Marital and
Family Therapy 2012;38(1):145-68.
Locke 1959
Locke HJ, Wallace KM. Short marital adjustment and prediction
tests: their reliability and validity. Marriage and Family Living
1959;21:251-5.
Madanes 1981
Madanes C. Strategic Family Therapy. San Francisco, CA: Jossey-
Bass Inc, 1981.
Minuchin 1974
Minuchin S. Families and Family Therapy. Cambridge, MA:
Harvard University Press, 1974.
Mohr 2009
Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD,
et al. The selection and design of control conditions for
randomized controlled trials of psychological interventions.
Psychotherapy and Psychosomatics 2009;78(5):275-84.
Monson 2004
Monson CM, Schnurr PP, Stevens SP, Guthrie KA. Cognitive-
behavioral couple's treatment for posttraumatic stress disorder:
initial findings. Journal of Traumatic Stress 2004;17(4):341-4.
Monson 2009
Monson CM, TaI CT, Fredman SJ. Military-related PTSD and
intimate relationships: from description to theory-driven
research and intervention development. Clinical Psychology
Review 2009;29(8):707-14.
Montori 2002
Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA,
Guyatt GH. In the dark: The reporting of blinding status in
randomized controlled trials. Journal of Clinical Epidemiology
2002;55(8):787-90.
Moos 1986
Moos R, Moos B. The Family Environment Scale manual. 2nd
Edition. Palo Alto: Consulting Psychologists Press, 1986.
Mueser & Glynn 1999
Mueser KT, Glynn SM. Behavioral family therapy for psychiatric
disorders. New York: Simon & Schuster, 1995.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
Mueser 1995
Mueser KT, Glynn SM. Behavioral family therapy for psychiatric
disorders. Boston: Allyn & Bacon, 1995.
Normand 1999
Normand ST. Meta-analysis: Formulating, evaluating,
combining, and reporting. Statistics in Medicine
1999;18(3):321-59.
Orcutt 2004
Orcutt HK, Erickson DJ, Wolfe J. The course of PTSD symptoms
among Gulf War veterans: a growth mixture modeling approach.
Journal of Traumatic Stress 2004;17(3):195-202.
Pavuluri 2004
Pavuluri MN, Graczyk PA, Henry DB, Carbray JA, Heidenreich J,
Miklowitz DJ. Child-and family-focused cognitive-behavioral
therapy for pediatric bipolar disorder: development and
preliminary results. Journal of the American Academy of Child
and Adolescent Psychiatry 2004;43(5):528-37.
Radlo; 1977
RadloG LS. The CES-D scale a self-report depression scale
for research in the general population. Applied Psychological
Measurement 1977;1(3):385-401.
Regier 2013
Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ,
Kuhl EA, et al. DSM-5 field trials in the United States and
Canada, part II: test-retest reliability of selected categorical
diagnoses. American Journal of Psychiatry 2013;170:59-70.
Review Manager 2014 [Computer program]
Nordic Cochrane Centre, The Cochrane Collaboration. Review
Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic
Cochrane Centre, The Cochrane Collaboration, 2014.
Riggs 2009
Riggs DS, Monson CM, Glynn S, Canterino J. Couples and family
therapy. In: Foa EB, Keane TM, Friedman MJ editor(s). EGective
treatments for PTSD: Practice guidelines from the International
Society for Traumatic Stress Studies. 2nd Edition. New York:
Guilford, 2009:458-478.
Roberts 2009
Roberts NP, Kitchiner NJ, Kenardy J, Bisson JI. Multiple session
early psychological interventions for the prevention of post-
traumatic stress disorder. Cochrane Database of Systematic
Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD006869.pub2]
Rose 2002
Rose SC, Bisson J, Churchill R, Wessely S. Psychological
debriefing for preventing post traumatic stress disorder (PTSD).
Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI:
10.1002/14651858.CD000560]
Sareen 2007
Sareen J, Cox BJ, Stein MB, Afifi TO, Fleet C, Asmundson GJG.
Physical and mental comorbidity, disability, and suicidal
behavior associated with posttraumatic stress disorder
in a large community sample. Psychosomatic Medicine
2007;69(3):242-8.
Sautter 2009
Sautter FJ, Glynn SM, Thompson KE, Franklin L, Han X. A couple-
based approach to the reduction of PTSD avoidance symptoms:
preliminary findings. Journal of Marital and Family Therapy
2009;35(3):343-9.
Schulz 2002
Schulz KF, Grimes DA. Allocation concealment in
randomised trials: defending against deciphering. Lancet
2002;359(9306):614-8.
Schünemann 2011
Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P,
Akl E, et al. on behalf of the Cochrane GRADEing Methods
Group and the Cochrane Statistical Methods Group. Chapter
11: Completing ‘Summary of findings’ tables and grading the
confidence in or quality of the evidence. In: Higgins JP, Churchill
R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook
for Systematic Reviews of Interventions version 5.2.0 (updated
June 2017). The Cochrane Collaboration, 2017. Available from
www.training.cochrane.org/handbook.
Sin 2017
Sin J, Spain D, Furuta M, Murrells T, Norman I. Psychological
interventions for post-traumatic stress disorder
(PTSD) in people with severe mental illness. Cochrane
Database of Systematic Reviews 2017, Issue 1. [DOI:
10.1002/14651858.CD011464.pub2]
Snyder 1989
Snyder DK, Wills RM. Behavioral versus insight-oriented marital
therapy: eGects on individual and interspousal functioning.
Journal of Consulting and Clinical Psychology 1989;57(1):39-46.
Snyder 2006
Snyder DK, Castellani AM, Whisman MA. Current status and
future directions in couple therapy. Annual Review of Psychology
2006;57:317-44.
Solomon 2006
Solomon Z, Mikulincer M. Trajectories of PTSD: a 20-
year longitudinal study. American Journal of Psychiatry
2006;163(4):659-66.
Spanier 1976
Spanier GB. Measuring dyadic adjustment: new scale for
assessing the quality of marriage and similar dyads. Journal of
Marriage and the Family 1976;38(1):15-28.
Spielberger 1988
Spielberger CD. Manual for the State-Trait Anxiety Inventory.
Manual for the State-Trait Anxiety Inventory. Palo Alto, CA:
Consulting Psychologists' Press, 1988.
Sprenkle 2004
Sprenkle DH, Blow AJ. Common factors and our sacred models.
Journal of Marital and Family Therapy 2004;30(2):113-29.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
Stein 2006
Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for
post traumatic stress disorder (PTSD). Cochrane
Database of Systematic Reviews 2006, Issue 1. [DOI:
10.1002/14651858.CD002795.pub2]
Sterne 2011
Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing
reporting biases. In: Higgins JPT, Green S (editors). Cochrane
Handbook for Systematic Reviews of Intervention. Version
5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
Available from www.cochrane-handbook.org.
Straus 1996
Straus MA, Hamby SL, McCoy SB, Sugarman DB. The revised
Conflict Tactics Scales (CTS2): development and preliminary
psychometric data. Journal of Family Issues 1996;17(3):283-316.
TaP 2007a
TaI CT, Kaloupek DG, Schumm JA, Marshall AD, Panuzio J,
King DW, et al. Posttraumatic stress disorder symptoms,
physiological reactivity, alcohol problems, and aggression
among military veterans. Journal of Abnormal Psychology
2007;116(3):498-507.
TaP 2007b
TaI CT, Street AE, Marshall AD, Dowdall DJ, Riggs DS.
Posttraumatic stress disorder, anger, and partner abuse
among Vietnam combat veterans. Journal of Family Psychology
2007;21(2):270-7.
TaP 2009
TaI CT, Monson CM, Schumm JA, Watkins LE, Panuzio J,
Resick PA. Posttraumatic Stress Disorder symptoms,
relationship adjustment, and relationship aggression in a
sample of female flood victims. Journal of Family Violence
2009;24(6):389-96.
TaP 2011
TaI CT, Watkins LE, StaGord J, Street AE, Monson CM.
Posttraumatic stress disorder and intimate relationship
problems: a meta-analysis. Journal of Consulting and Clinical
Psychology 2011;79(1):22-33.
Tarrier 1999
Tarrier N, Sommerfield C, Pilgrim H. Relatives' expressed
emotion (EE) and PTSD treatment outcome. Psychological
Medicine 1999;29(4):801-11.
Ware 2000
Ware J, Kosinski M, Gandek B. Overview of the SF-36. SF-36
health survey: manual and interpretation guide. Lincoln:
Quality Metric Incorporated, 2000.
Weathers 1993
Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The
PTSD Checklist (PCL): reliability, validity, and diagnostic
utility. Paper presented at the 9th Annual Conference of the
International Society for Traumatic Stress Studies (ISTSS), San
Antonio, TX, October, 1993.
Weathers 2001
Weathers FW, Keane TM, Davidson JRT. Clinician-administered
PTSD scale: a review of the first ten years of research. Depression
and Anxiety 2001;13(3):132-56.
Wood 2006
Wood J J, Piacentini JC, Southam-Gerow M, Chu BC, Sigman M.
Family cognitive behavioral therapy for child anxiety disorders.
Journal of the American Academy of Child and Adolescent
Psychiatry 2006;45(3):314-21.
 
References to other published versions of this review
Cowlishaw 2014
Cowlishaw S, Evans L, Suomi A, Rodgers B. Couple and
family therapies for post-traumatic stress disorder (PTSD).
Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI:
10.1002/14651858.CD011257]
 
* Indicates the major publication for the study
 
C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Methods Study design: randomised controlled trial
Participants Sample size: 120 PTSD (60) and their partners (60)
Age: PTSD mean 41.2 (SD 4.2) years, partners mean 36.5 (SD 5.4) years
Sex: not reported
Location: Iran, two major veterans' affairs clinics in Tehran: Baqiyatallah and Sadr hospitals
Interventions Intervention: cognitive behavioural couples' therapy (CBCT)
Ahmady 2009 
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Co-morbidities: spinal cord injuries and other injuries affecting sexual functioning and opium addic-
tions were excluded
Outcomes Timepoints: only post-treatment
Primary (and only) outcome: ENRICH marital adjustment test
Notes Dates: 2007 to 2008
Significant amount of information missing in the publication.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)





High risk Participants seem aware that they were receiving treatment
Blinding of outcome as-
sessment (detection bias) 
All outcomes




High risk Primary outcome (PTSD severity) missing
Selective reporting (re-
porting bias)
High risk No protocol available




Methods Study design: randomised controlled trial
Participants Sample size: 29 PTSD-diagnosed Vietnam veterans and their family members (58 participants)
Age: PTSD mean 37.11 (SD 11.27) years, family members' age not reported
Sex: PTSD 100% male, family members not reported
Location: Veterans Affairs Medical Center, West Los Angeles
Interventions Intervention 1: direct therapeutic exposure (DTE)
Intervention 2: behavioural family therapy (BFT) as an adjunct therapy
Comorbidities: severe cardiovascular disease, organic brain, psychotic, or severe dissociative disorder,
current substance dependence, and physical aggression to self or others within the preceding year ex-
cluded
Glynn 1999 
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Adjunctive medication: 81% of the veterans on psychotropic medication, participants to maintain a
stable medication regimen during the trial
Outcomes Timepoints for assessment: baseline, post treatment and 6-month follow-up
Primary outcome: PTSD positive symptoms, PTSD negative symptoms (composite scores using select-
ed CAPS, M-PTSD and IOE subscales)
Secondary outcome: Social Adjustment Scale (SAS)
Notes Funding: VA Health Services and Research Development Merit Review Grant IIR 006
Declarations of interests: n/a
Dates: n/a, prior to 1997
Published data does not contain enough information to be included in the meta-analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Randomisation sequential balancing strategy with randomisation odds to per-
mit 50% likelihood for one adjunct therapy group and 25% likelihood for the
two other groups (individual therapy group and wait list condition)
Allocation concealment
(selection bias)





High risk No blinding, participants and personnel were aware of intervention provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes




High risk Most measures from baseline not reported at follow-up
Selective reporting (re-
porting bias)
Unclear risk No protocol or trial registration available




Methods Study design: randomised controlled study
Participants Sample size: 40 PTSD-diagnosed people and their partners (80 participants)
Age: PTSD mean 37.11 (SD 11.27) years, partner mean 37.82 (SD 11.55) years
Sex: PTSD 25.0% male, partners 67.5% male
Monson 2012 
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Location: Department of Veterans Affairs outpatient hospital in Boston, USA and a university-based re-
search centre in Toronto, Canada.
Interventions Intervention: Cognitive behavioural conjoint therapy (CBCT)
Co-morbidities: substance dependence, current bipolar and psychotic disorder excluded
Adjunctive therapy: other concurrent couple or individual therapies excluded
Adjunctive medication: participants asked to maintain a stable psychotropic medication regimen dur-
ing the trial
Outcomes Timepoints for assessment: baseline, mid-treatment, post-treatment and 3-month follow-up
Primary outcome: CAPS
Secondary outcome: DAS, PCL, BDI and Stai-Trait
Notes Funding: National Institute of Mental Health
Declarations of interest: full COI included
Dates: 2008 to 2012
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A computer random number generator for random assignment
Allocation concealment
(selection bias)
Low risk "Allocation results were concealed with separate privacy envelopes that were





High risk No blinding, participants and personnel were aware of intervention provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes





Low risk All outcomes reported for the whole sample, intention-to-treat analysis and
handling of missing data reported
Selective reporting (re-
porting bias)
Low risk Protocol available and all pre-specified outcomes reported




Methods Study design: randomised controlled trial
Participants Sample size: 57 PTSD-diagnosed veterans and their partners (114 participants)
Sautter 2015 
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Age: PTSD mean 33.12 (SD 6.56) years, partners mean 32.21 (SD 7.71) years
Sex: PTSD 98.2% male, partners 1.8% male
Location: Southeast Louisiana Veterans Affairs Health Care, USA.
Interventions Intervention: Structural approach therapy (SAT)
Co-morbidities: n/a
Adjunctive therapy: other concurrent couple therapies excluded.
Adjunctive medication: 57.1% of the veterans on psychotropic medication, participants to maintain a
stable medication regimen during the trial.
Outcomes Timepoints for assessment: baseline, post-treatment and 12-week follow-up.
Primary outcome: CAPS
Secondary outcomes: PCL, DA, STAI-State, CES-D
Notes Funding: in part by MERIT Review grant (B6756R) from the VA Rehabilitation and Development pro-
gram and Supplemental Funding Award from the South Central Mental Illness Research Education and
Clinical Center to Professor Sautter.
Declarations of interest: none declared
Dates: 2010 to 2013
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)





High risk No blinding, participants and personnel aware of the intervention provided
Blinding of outcome as-
sessment (detection bias) 
All outcomes




Low risk Intention-to-treat analyses and handling of missing data reported
Selective reporting (re-
porting bias)
Low risk Protocol available and all pre-specified outcome measures reported
Other bias Low risk n/a
Sautter 2015  (Continued)
BDI: Beck Depression Inventory
CAPS: Clinician- Administered PTSD Scale
CBCT: cognitive behavioural conjoint/couple's therapy
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CES-D: Center for Epidemiological Studies Depression Scale
DAS: Depression, Anxiety and Stress Scale
IOE: Impact of Events Scale
M-PTSD: Mississippi Scale for Combat-Related Posttraumatic Stress Disorder
PCL: PTSD Checklist
PTSD: post-traumatic stress disorder
SD: standard deviation
Stai-Trait: State-Trait Anxiety Inventory
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Cahoon 1984 Allocation: Non-random, no comparison group
Participants: Vietnam veterans and their spouses
Intervention: Couple's group therapy
Heinrichs 2012 Allocation: Randomised
Participants: Couples in the context of cancer treatment, no PTSD measurement
Intervention: Couple-based skills training vs control group
Holditch-Davis 2014 Allocation: Randomised
Participants: Mothers of pre-term infants
Interventions: Auditory–tactile–visual–vestibular (ATVV) intervention and kangaroo care (KC) and
control group (no couple's/family therapy)
Jones 2004 Allocation: Randomised
Participants: Family members of patients in ICU
Intervention: 6-week self-help manual containing information about recovery from ICU, psycholog-
ical information and practical advice for the family member vs control group (no couple's/family
therapy)
Jones 2012 Allocation: Non-random, no comparison group
Participants: Family members of patients in ICU
Intervention: Provision of the patient diary on their PTSD-related symptoms to the family member
vs control group (no couple's/family therapy)
Kersting 2013 Allocation: Randomised
Participants: Parents who have lost their child during pregnancy
Intervention: Brief internet-based intervention vs control group (no couple's/family therapy)
King 2000 Allocation: Randomised
Participants: Sexually abused children with PTSD (no adult participants with PTSD)
Intervention: Family Cognitive-Behavioral Treatment (FBCT) vs control group
Knox 2016 Allocation: Non-random, participants were allocated based on a need assessment.
Participants: Married military members and military spouses who had experienced a traumatic
event
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Study Reason for exclusion
Interventions: Emotionally Focused Therapy (EFT), Eye Movement Desensitization and Reprocess-
ing (EMDR) and control group.
Landy 2015 Allocation: Non-random
Participants: Parents with PTSD
Interventions: Cognitive-Behavioral Conjoint Therapy (CBCT), no control group
Zimmermann 2016 Allocation: Not clear
Participants: Couples where one person is diagnosed with cancer (no PTSD measure)
Intervention: Couples-based skills training
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods Study design: randomised controlled trial
Participants Sample size: 92: 46 PTSD-diagnosed veterans and their partners
Age: mean 39.9 (SD 10.3) years
Sex: PTSD 89.1% males, 10.9% females
Location: VA Medical Center, Indianapolis, US
Interventions Intervention 1: mindfulness-based cognitive behavioural conjoint therapy (CBCT) for PTSD
Intervention 2: active comparator, CBCT-PTSD communication component
Co-morbidities: IPV, current suicidal/homicidal intent or self-injury, cognitive impairment, current
substance dependence, PTSD diagnosis in the partner, uncontrolled psychotic of bipolar disorder
excluded
Outcomes Timepoints for assessment: baseline, post-treatment (10 weeks after session 1)
Primary outcome: CAPS
Secondary outcome: DAS, PCL, BDI and Stai-Trait
Notes Trial completed in 2015, main outcomes now available (most recent update November 2018) on
ClinicalTrials.gov, and authors communicate that a primary paper will be submitted in 2019. It is




Methods Study design: randomised controlled trial
Participants Sample size: 24 (unclear whether this is the number of couples or individuals)
Age: 18 years and above
Sex: All sexes were eligible
NCT01627548 
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Location: UCLA Welcome Back Veterans Center
Interventions Intervention: Structured Approach Therapy (SAT), 12 weekly 50 minute sessions
Control: Wait-list (delayed intervention) for 4 months
Co-morbidities: IPV, substance dependence, past 3 month psychotic symptoms excluded
Outcomes Timepoints for assessment: baseline, post-treatment (4-6 months)
Primary outcome: Improved couples communication as measured by standardised assessments
Secondary outcome: n/a





Methods Study design: randomised controlled trial
Participants 64 couples (128 individuals)
Interventions Intervention 1: individual PE
Intervention 2: couple's CBT
Co-morbidities: Recent suicidal ideation alcohol dependence, cognitive impairment, PTSD diagno-
sis in the partner, uncontrolled psychotic of bipolar disorder excluded
Outcomes Primary outcome: CAPS, PCL at 12 weeks
Secondary outcome: CAPS, PCL at 3, 6, 12 months and Couple's Satisfaction Index at 12 weeks, 3,
6, and 12 months.
Notes Trial completed in 2016, pending publication
NCT02336971 
BDI: Beck Depression Inventory
CBCT: cognitive behavioural conjoint therapy
CAPS: Clinician- Administered PTSD Scale
DAS: Depression, Anxiety and Stress Scale
IPV: intimate partner violence
PCL: PTSD Checklist
PTSD: post-traumatic stress disorder
SD: standard deviation
Stai-Trait: State-Trait Anxiety Inventory
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Cognitive-Behavioral Conjoint Therapy (CBCT) Project
Methods Study design: randomised controlled trial
Participants 360 participants (estimated enrolment)
NCT02720016 
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Interventions Intervention 1: CBCT-home based (CBCT-HB)
Intervention 2: CBCT-office based (CBCT-OB) (active comparator)
Intervention 3: PTSD family education (PFE) (active comparator)
Outcomes Primary outcomes: CAPS, Couples Satisfaction Index (CSI), Inventory of Psychosocial Functioning
(IPF); Client Satisfaction Questionnaire (CSQ), Working Alliance Inventory- short form (WAI-S)
Secondary outcomes: PCL, BDI, State-Trait Anger Expression Inventory (STAXI), Conflict Tactics
Scale Short Form (CTS-2S)
Starting date October 2016
Contact information Daniel Barlam, Leslie Morland
Notes Estimated study completion date: 2020
NCT02720016  (Continued)
BDI: Beck Depression Inventory
CAPS: Clinician- Administered PTSD Scale
CBCT: cognitive behavioural conjoint therapy
DAS: Depression, Anxiety and Stress Scale
PCL: PTSD Checklist
PTSD: post-traumatic stress disorder
Stai-Trait: State-Trait Anxiety Inventory
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Stand-alone couple or family therapy versus no treatment





Statistical method Effect size
1 Severity of PTSD symptoms 1 40 Std. Mean Difference (IV, Random,
95% CI)
-1.12 [-1.79, -0.45]
2 Dyadic adjustment 2 100 Std. Mean Difference (IV, Random,
95% CI)
1.07 [-0.17, 2.31]
3 Family member severity of depression 1 40 Std. Mean Difference (IV, Fixed,
95% CI)
0.28 [-0.35, 0.90]
4 Family member severity of anxiety 1 40 Std. Mean Difference (IV, Fixed,
95% CI)
0.15 [-0.47, 0.77]
5 Severity of depression 1 40 Std. Mean Difference (IV, Random,
95% CI)
-0.66 [-1.30, -0.02]
6 Severity of anxiety 1 40 Std. Mean Difference (IV, Random,
95% CI)
-0.93 [-1.58, -0.27]
7 Treatment dropout (treatment accept-
ability)
1 40 Odds Ratio (M-H, Random, 95% CI) 0.41 [0.09, 1.95]
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Analysis 1.1.   Comparison 1 Stand-alone couple or family therapy
versus no treatment, Outcome 1 Severity of PTSD symptoms.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Monson 2012 20 33.5 (24.4) 20 60.8 (23.4) 100% -1.12[-1.79,-0.45]
   
Total *** 20   20   100% -1.12[-1.79,-0.45]
Heterogeneity: Not applicable  
Test for overall effect: Z=3.27(P=0)  
Favours CBCT 42-4 -2 0 Favours waiting list
 
 
Analysis 1.2.   Comparison 1 Stand-alone couple or family
therapy versus no treatment, Outcome 2 Dyadic adjustment.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Ahmady 2009 30 44.9 (38.2) 30 -2.6 (8.4) 50.32% 1.7[1.1,2.29]
Monson 2012 20 110.2 (19.8) 20 101.5 (19.5) 49.68% 0.43[-0.19,1.06]
   
Total *** 50   50   100% 1.07[-0.17,2.31]
Heterogeneity: Tau2=0.7; Chi2=8.17, df=1(P=0); I2=87.76%  
Test for overall effect: Z=1.69(P=0.09)  
Favours waitlist 42-4 -2 0 Favours CBCT
 
 
Analysis 1.3.   Comparison 1 Stand-alone couple or family therapy
versus no treatment, Outcome 3 Family member severity of depression.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Monson 2012 20 9.5 (8.7) 20 7.2 (8) 100% 0.28[-0.35,0.9]
   
Total *** 20   20   100% 0.28[-0.35,0.9]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.87(P=0.39)  
Favours CBCT 42-4 -2 0 Favours waitlist
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Analysis 1.4.   Comparison 1 Stand-alone couple or family therapy
versus no treatment, Outcome 4 Family member severity of anxiety.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Monson 2012 20 37.8 (11.5) 20 36.1 (10.8) 100% 0.15[-0.47,0.77]
   
Total *** 20   20   100% 0.15[-0.47,0.77]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.47(P=0.64)  
Favours CBCT 42-4 -2 0 Favours waitlist
 
 
Analysis 1.5.   Comparison 1 Stand-alone couple or family
therapy versus no treatment, Outcome 5 Severity of depression.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Monson 2012 20 12.2 (12.4) 20 20.3 (11.8) 100% -0.66[-1.3,-0.02]
   
Total *** 20   20   100% -0.66[-1.3,-0.02]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.03(P=0.04)  
Favours CBCT 42-4 -2 0 Favours waitlist
 
 
Analysis 1.6.   Comparison 1 Stand-alone couple or family
therapy versus no treatment, Outcome 6 Severity of anxiety.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Monson 2012 20 38.7 (14.3) 20 51.7 (13.4) 100% -0.93[-1.58,-0.27]
   
Total *** 20   20   100% -0.93[-1.58,-0.27]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=2.77(P=0.01)  
Favours CBCT 42-4 -2 0 Favours waitlist
 
 
Analysis 1.7.   Comparison 1 Stand-alone couple or family therapy versus
no treatment, Outcome 7 Treatment dropout (treatment acceptability).
Study or subgroup Couple / fam-
ily therapy
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Monson 2012 14/20 17/20 100% 0.41[0.09,1.95]
   
Total (95% CI) 20 20 100% 0.41[0.09,1.95]
Favours CBCT 500.02 100.1 1 Favours waiting list
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Study or subgroup Couple / fam-
ily therapy
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Total events: 14 (Couple / family therapy), 17 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.12(P=0.26)  
Favours CBCT 500.02 100.1 1 Favours waiting list
 
 
Comparison 2.   Stand-alone couple or family therapy versus other structured or non-specific intervention





Statistical method Effect size
1 Severity of PTSD symptoms 1 57 Std. Mean Difference (IV, Random,
95% CI)
-1.32 [-1.90, -0.74]
2 Dyadic adjustment 1 57 Std. Mean Difference (IV, Random,
95% CI)
0.01 [-0.51, 0.53]
3 Family member severity of depression 1 57 Std. Mean Difference (IV, Fixed,
95% CI)
0.21 [-0.31, 0.73]
4 Family member severity of anxiety 1 57 Std. Mean Difference (IV, Fixed,
95% CI)
-0.16 [-0.68, 0.36]
5 Severity of depression 1 57 Std. Mean Difference (IV, Random,
95% CI)
-0.28 [-0.81, 0.24]
6 Severity of anxiety 1 57 Std. Mean Difference (IV, Random,
95% CI)
-0.34 [-0.87, 0.18]
7 Treatment dropout (treatment accept-
ability)
1 57 Odds Ratio (M-H, Random, 95% CI) 0.95 [0.29, 3.19]
 
 
Analysis 2.1.   Comparison 2 Stand-alone couple or family therapy versus other
structured or non-specific intervention, Outcome 1 Severity of PTSD symptoms.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Sautter 2015 29 44.6 (20.4) 28 71.9 (20.4) 100% -1.32[-1.9,-0.74]
   
Total *** 29   28   100% -1.32[-1.9,-0.74]
Heterogeneity: Not applicable  
Test for overall effect: Z=4.49(P<0.0001)  
Favours SAT 42-4 -2 0 Favours PFE
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Analysis 2.2.   Comparison 2 Stand-alone couple or family therapy versus
other structured or non-specific intervention, Outcome 2 Dyadic adjustment.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Sautter 2015 29 105.5 (20.7) 28 105.3 (20.6) 100% 0.01[-0.51,0.53]
   
Total *** 29   28   100% 0.01[-0.51,0.53]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.03(P=0.97)  
Favours SAT 42-4 -2 0 Favours PFE
 
 
Analysis 2.3.   Comparison 2 Stand-alone couple or family therapy versus other structured
or non-specific intervention, Outcome 3 Family member severity of depression.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Sautter 2015 29 18.6 (14.6) 28 15.5 (14.4) 100% 0.21[-0.31,0.73]
   
Total *** 29   28   100% 0.21[-0.31,0.73]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.78(P=0.44)  
Favours SAT 42-4 -2 0 Favours PFE
 
 
Analysis 2.4.   Comparison 2 Stand-alone couple or family therapy versus other
structured or non-specific intervention, Outcome 4 Family member severity of anxiety.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Sautter 2015 29 33.9 (14.7) 28 36.3 (14.8) 100% -0.16[-0.68,0.36]
   
Total *** 29   28   100% -0.16[-0.68,0.36]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.61(P=0.54)  
Favours SAT 42-4 -2 0 Favours PFE
 
 
Analysis 2.5.   Comparison 2 Stand-alone couple or family therapy versus other
structured or non-specific intervention, Outcome 5 Severity of depression.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Sautter 2015 29 24.7 (13.1) 28 28.5 (13.1) 100% -0.28[-0.81,0.24]
   
Total *** 29   28   100% -0.28[-0.81,0.24]
Favours SAT 42-4 -2 0 Favours PFE
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Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=1.07(P=0.29)  
Favours SAT 42-4 -2 0 Favours PFE
 
 
Analysis 2.6.   Comparison 2 Stand-alone couple or family therapy versus
other structured or non-specific intervention, Outcome 6 Severity of anxiety.
Study or subgroup Couple / fam-
ily therapy
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Sautter 2015 29 39.6 (14.3) 28 44.6 (14.1) 100% -0.34[-0.87,0.18]
   
Total *** 29   28   100% -0.34[-0.87,0.18]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.29(P=0.2)  
Favours SAT 42-4 -2 0 Favours PFE
 
 
Analysis 2.7.   Comparison 2 Stand-alone couple or family therapy versus other structured
or non-specific intervention, Outcome 7 Treatment dropout (treatment acceptability).
Study or subgroup Couple / fam-
ily therapy
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Sautter 2015 7/29 7/28 100% 0.95[0.29,3.19]
   
Total (95% CI) 29 28 100% 0.95[0.29,3.19]
Total events: 7 (Couple / family therapy), 7 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.08(P=0.94)  
Favours SAT 500.02 100.1 1 Favours PFE
 
 
Comparison 3.   Adjunctive couple or family therapy versus structured or non-specific individual therapy alone




Statistical method Effect size
1 Treatment dropout (treatment acceptabil-
ity)
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Analysis 3.1.   Comparison 3 Adjunctive couple or family therapy versus structured or non-
specific individual therapy alone, Outcome 1 Treatment dropout (treatment acceptability).
Study or subgroup Couple / fam-
ily therapy
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Glynn 1999 6/17 0/12 100% 14.13[0.71,279.83]
   
Total (95% CI) 17 12 100% 14.13[0.71,279.83]
Total events: 6 (Couple / family therapy), 0 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.74(P=0.08)  
Favours individual treatm 2000.005 100.1 1 Favours adj family therap
 
 
A P P E N D I C E S
Appendix 1. Details of the CCMDCTR
Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR)
The Cochrane Common Mental Disorders Group maintains an archived specialised register of RCTs, the CCMDCTR. This register contains
over 40,000 reference records (reports of RCTs) for anxiety disorders, depression, bipolar disorder, eating disorders, self-harm and other
mental disorders within the scope of this Group. The CCMDCTR is a partially studies-based register with more than 50 percent of reference
records tagged to around 12,500 individually PICO-coded study records. Reports of trials for inclusion in the register were collated
from (weekly) generic searches of key bibliographic databases to June 2016, which included: Ovid MEDLINE (1950 onwards), Embase
(1974 onwards) and PsycINFO (1967 onwards), Cochrane Central Register of Controlled Trials (CENTRAL) and review-specific searches
of additional databases. Reports of trials were also sourced from international trial registries, drug companies, the handsearching of
key journals, conference proceedings and other (non-Cochrane) systematic reviews and meta-analyses. Details of CCMD's core search
strategies (used to identify RCTs) can be found on the Cochrane Common Mental Disorders website, with an example of the core MEDLINE
search displayed in Appendix 1.
The CCMDCTR is hosted and maintained on the new Cochrane Register of Studies (CRS) meta-register, which allows for leI- and right-hand
truncation of search terms. The register fell out of date in June 2016 when the Editorial Group moved from the University of Bristol to the
University of York.
The search strategy listed below is the weekly OVID MEDLINE search which was used to inform Cochrane Common Mental Disorders
specialised register. It was based on a list of terms for all conditions within the scope of Cochrane Common Mental Disorders plus
a sensitive RCT filter.
1. [MeSH Headings]:
eating disorders/ or anorexia nervosa/ or binge-eating disorder/ or bulimia nervosa/ or female athlete triad syndrome/ or pica/ or
hyperphagia/ or bulimia/ or self-injurious behavior/ or self mutilation/ or suicide/ or suicidal ideation/ or suicide, attempted/ or
mood disorders/ or aGective disorders, psychotic/ or bipolar disorder/ or cyclothymic disorder/ or depressive disorder/ or depression,
postpartum/ or depressive disorder, major/ or depressive disorder, treatment-resistant/ or dysthymic disorder/ or seasonal aGective
disorder/ or neurotic disorders/ or depression/ or adjustment disorders/ or exp antidepressive agents/ or anxiety disorders/ or
agoraphobia/ or neurocirculatory asthenia/ or obsessive-compulsive disorder/ or obsessive hoarding/ or panic disorder/ or phobic
disorders/ or stress disorders, traumatic/ or combat disorders/ or stress disorders, post-traumatic/ or stress disorders, traumatic, acute/
or anxiety/ or anxiety, castration/ or koro/ or anxiety, separation/ or panic/ or exp anti-anxiety agents/ or somatoform disorders/ or body
dysmorphic disorders/ or conversion disorder/ or hypochondriasis/ or neurasthenia/ or hysteria/ or munchausen syndrome by proxy/ or
munchausen syndrome/ or fatigue syndrome, chronic/ or obsessive behavior/ or compulsive behavior/ or behavior, addictive/ or impulse
control disorders/ or firesetting behavior/ or gambling/ or trichotillomania/ or stress, psychological/ or burnout, professional/ or sexual
dysfunction, psychological/ or vaginismus/ or Anhedonia/ or AGective Symptoms/ or *Mental Disorders/
2. [Title/ Author Keywords]:
(eating disorder* or anorexia nervosa or bulimi* or binge eat* or (self adj (injur* or mutilat*)) or suicide* or suicidal or parasuicid* or
mood disorder* or aGective disorder* or bipolar i or bipolar ii or (bipolar and (aGective or disorder*)) or mania or manic or cyclothymic* or
depression or depressive or dysthymi* or neurotic or neurosis or adjustment disorder* or antidepress* or anxiety disorder* or agoraphobia
or obsess* or compulsi* or panic or phobi* or ptsd or posttrauma* or post trauma* or combat or somatoform or somati#ation or medical*
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unexplained or body dysmorphi* or conversion disorder or hypochondria* or neurastheni* or hysteria or munchausen or chronic fatigue*
or gambling or trichotillomania or vaginismus or anhedoni* or aGective symptoms or mental disorder* or mental health).ti,kf.
3. [RCT filter]:
(controlled clinical trial.pt. or randomized controlled trial.pt. or (randomi#ed or randomi#ation).ab,ti. or randomly.ab. or (random* adj3
(administ* or allocat* or assign* or class* or control* or determine* or divide* or distribut* or expose* or fashion or number* or place*
or recruit* or subsitut* or treat*)).ab. or placebo*.ab,ti. or drug therapy.fs. or trial.ab,ti. or groups.ab. or (control* adj3 (trial* or study or
studies)).ab,ti. or ((singl* or doubl* or tripl* or trebl*) adj3 (blind* or mask* or dummy*)).mp. or clinical trial, phase ii/ or clinical trial, phase
iii/ or clinical trial, phase iv/ or randomized controlled trial/ or pragmatic clinical trial/ or (quasi adj (experimental or random*)).ti,ab. or
((waitlist* or wait* list* or treatment as usual or TAU) adj3 (control or group)).ab.)
4. (1 and 2 and 3)
Records were screened for reports of RCTs within the scope of the Cochrane Common Mental Disorders Group. Secondary reports of RCTs
were tagged to the appropriate study record.
Similar weekly search alerts were also conducted on OVID Embase and PsycINFO, using relevant subject headings (controlled vocabularies)
and search syntax, as appropriate to each resource.
A quarterly search of the Cochrane Central Register of Controlled Trials (CENTRAL) was conducted c/o the Cochrane Register of Studies
Online (CRSO).
Appendix 2. Other database searches (to March 2018)
In March 2018, records retrieved from a much larger search, for a suite of PTSD reviews, were screened for trials relevant to this review.
The search was based on population or psychological debriefing (only) (+ RCT filter, where appropriate), details below.
Date of search: 3 March 2018








Duplicates removed = 4620
Studies screened for RCTs = 4797
Records excluded = 3632
RCT records identified = 1165
Databases: CENTRAL
Cochrane Central Register of Controlled Trials : Issue 2 of 12, February 2018
Date Searched: March 3rd 2018
#1 MeSH descriptor: [Stress Disorders, Post-Traumatic] this term only (1492)
#2 (PTSD or ((posttrauma* or post-trauma* or post trauma*) near/3 (stress* or disorder* or psych* or symptom*)) or acute stress disorder*
or combat disorder* or war neuros*) (5065)
#3 (((acute or traumatic) near/1 stress*) and (expos* or psyc*)) (1525)
#4 (traumatised near/1 (victim* or survivor*)) 2
#5 (traumatized near/1 (victim* or survivor*)) 4
#6 (trauma* near/2 (event* or memor* or flashback* or nightmare*)) 553
#7 ((trauma* or posttrauma* or post-trauma* or victim* or survivor*) and (exposure near/3 (therap* or psychotherap* or training or
counsel*))) 417
#8 MeSH descriptor: [Crisis Intervention] this term only 166
#9 (critical incident near/1 (stress or debrief* or de-brief*)) 24
#10 (debriefing or de-briefing) 328
#11 (crisis intervention* or CISD) 1003
#12 ((stress or group* or psychological or crisis) near/3 (debrief* or de-brief*)) 107
#13 (trauma* near/2 (event* or memor* or flashback* or nightmare*)) 553
#14 (EMDR or (eye movement desensitization and reprocessing)) 225
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#15 (EMDR or (eye movement desensitisation and reprocessing)) 197
#16 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15)
#17 MeSH descriptor: [Stress Disorders, Post-Traumatic] this term only
Publication Year from 2014 to 2018 (2893)
File: VO1 CENTRAL n2028.txt
***************************
Databases: Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid
MEDLINE(R) 1946 to Present
Date Searched: March 3rd 2018
1 Stress Disorders, Post-Traumatic/ 27503
2 (PTSD or ((posttrauma* or post-trauma* or post trauma*) adj3 (stress* or disorder* or psych* or symptom?)) or acute stress disorder* or
combat disorder* or war neuros*).ti,ab,kf. 31111
3 (((acute or traumatic) adj stress*) and (expos* or psyc*)).ti,ab,kf. 10567
4 (traumati#ed adj (victim? or survivor?)).ti,ab,kf. 34
5 (trauma* adj2 (event? or memor* or flashback* or nightmare?)).ti,ab,kf. 8174
6 ((trauma* or posttrauma* or post-trauma* or victim* or survivor?) and (exposure adj3 (therap* or psychotherap* or training or
counsel*))).ti,ab,kf,hw. 901
7 Crisis Intervention/ 5457
8 (critical incident adj (stress or debrief* or de-brief*)).ti,ab,kf. 223
9 (debriefing or de-briefing).ti,kf. 577
10 (crisis intervention? or CISD).ti,ab,kf.1744
11 ((stress or group? or psychological or crisis) adj3 (debrief* or de-brief*)).ti,ab,kf. 406
12 (trauma* adj2 (event? or memor* or flashback* or nightmare?)).ti,kf. 1150
13 (EMDR or (eye movement desensiti#ation and reprocessing)).ti,ab,kf,sh. 510
14 (1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13) 52168
15 randomized controlled trial.pt. 454849
16 controlled clinical trial.pt. 92204
17 randomized.ab. 404382
18 placebo.ab. 186843
19 clinical trials as topic.sh. 182777
20 randomly.ab. 285994
21 trial.ti. 178689
22 (15 or 16 or 17 or 18 or 19 or 20 or 21) 1136215
23 (14 and 22) 4000
24 (2014* or 2015* or 2016* or 2017* or 2018*).yr,dt,ed,ep. 5444042




1 posttraumatic stress disorder/ 48854
2 "trauma and stressor related disorders"/ 34962
3 combat disorders/ 26663
4 psychological trauma/ 5351
5 stress disorders, post-traumatic/ 16743
6 stress disorders, traumatic, acute/ 751
7 (PTSD or ((posttrauma* or post-trauma* or post trauma*) adj3 (stress* or disorder* or psych* or symptom?)) or acute stress disorder* or
combat disorder* or war neuros*).ti,ab,kw. 39945
8 (((acute or traumatic) adj stress*) and (expos* or psyc*)).ti,ab,kw. 15122
9 (traumati#ed adj (victim? or survivor?)).ti,ab,kw. 51
10 (trauma* adj2 (event? or memor* or flashback* or nightmare?)).ti,ab,kw. 10514
11 (EMDR or (eye movement desensiti#ation and reprocessing)).ti,kw. 527
12 ((trauma* or posttrauma* or post-trauma* or victim* or survivor?) and (exposure adj3 (therap* or psychotherap* or training or
counsel*))).ti,ab,kw. 1096
13 (critical incident adj (stress or debrief* or de-brief*)).ti,ab,kw. 275
14 (debriefing or de-briefing).ti,ab,kw. 4133
15 (crisis intervention? or CISD).ti,ab,kw. 2273
16 ((stress or group? or psychological or crisis) adj3 (debrief* or de-brief*)).ti,ab,kw. 602
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17 (trauma* adj2 (event? or memor* or flashback* or nightmare?)).ti,ab,kw. 10514
18 (1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17) 74063
19 crossover-procedure/ or double-blind procedure/ or randomized controlled trial/ or single-blind procedure/ or (random* or factorial*
or crossover* or cross over* or placebo* or (doubl* adj blind*) or (singl* adj blind*) or assign* or allocat* or volunteer*).tw. 1970074
20 (18 and 19) 7601
21 (2014* or 2015* or 2016* or 2017* or 2018*).yr,dc. 7084132
22 (20 and 21) 3319
***************************
Ovid PsycINFO
Date Searched: March 3rd 2018
1 posttraumatic stress disorder/ or complex ptsd/ or desnos/ or acute stress disorder/ or combat experience/ or "debriefing
(psychological)"/ or emotional trauma/ or post-traumatic stress/ or exp stress reactions/ or traumatic neurosis/ 50806
2 exp disasters/ 8186
3 (PTSD or ((posttrauma* or post-trauma* or post trauma*) adj3 (stress* or disorder* or psych* or symptom?)) or acute stress disorder* or
combat disorder* or war neuros*).ti,ab. 38985
4 (((acute or traumatic) adj stress*) and (expos* or psyc*)).ti,ab. 16755
5 (traumati#ed adj (victim? or survivor?)).ti,ab. 68
6 (trauma* adj2 (event? or memor* or flashback* or nightmare?)).ti,ab. 11819
7 (EMDR or (eye movement desensiti#ation and reprocessing)).ti,ab. 1640
8 ((trauma* or posttrauma* or post-trauma* or victim* or survivor?) and (exposure adj3 (therap* or psychotherap* or training or
counsel*))).ti,ab. 1086
9 crisis intervention/ 3314
10 (critical incident adj (stress or debrief* or de-brief*)).ti,ab. 443
11 (debriefing or de-briefing).ti,ab. 2186
12 (crisis intervention? or CISD).ti,ab. 3505
13 ((stress or group? or psychological or crisis) adj3 (debrief* or de-brief*)).ti,ab. 596
14 (trauma* adj2 (event? or memor* or flashback* or nightmare?)).ti,ab. 11819
15 (1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14) 80813
16 clinical trials.sh. 10820
17 (randomi#ed or randomi#ation or randomi#ing).ti,ab,id. 72509
18 (RCT or at random or (random* adj3 (assign* or allocat* or control* or crossover or cross-over or design* or divide* or division or
number))).ti,ab,id. 82020
19 (control* and (trial or study or group) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,id,hw.25590
20 ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,id. 24054
21 trial.ti. 25583
22 placebo.ti,ab,id,hw. 37267
23 treatment outcome.md. 18762
24 treatment eGicacy evaluation.sh. 21858
25 mental health program evaluation.sh. 2028
26 (16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25) 169119
27 (15 and 26) 4124
28 (2014* or 2015* or 2016* or 2017* or 2018*).yr,dc,mo. 782907
29 (27 and 28) 1449
***************************
Database: PILOTS: Published International Literature On Traumatic Stress
Date Searched: March 3rd 2018
Search Strategy
Set#: S1 Searched for: ti((posttrauma* near/4 (stress* or disorder* or psych* or symptom*))) OR ab((posttrauma* near/4 (stress* or disorder*
or psych* or symptom*))) Results: 16999*
Set#: S2 Searched for: ti((post-trauma* near/4 (stress* or disorder* or psych* or symptom*))) OR ab((post-trauma* near/4 (stress* or
disorder* or psych* or symptom*))) Results: 6647°
Set#: S3 Searched for: ti((post trauma* near/4 (stress* or disorder* or psych* or symptom*))) OR ab((post trauma* near/4 (stress* or
disorder* or psych* or symptom*))) Results: 7214°
Set#: S4 Searched for: ti((PTSD or acute stress disorder* or combat disorder* or war neuros*) ) OR ab((PTSD or acute stress disorder* or
combat disorder* or war neuros*) ) Results: 30435*
Set#: S5 Searched for: ti((((acute or traumatic) near/2 stress*) and (expos* or psyc*)) ) OR ab((((acute or traumatic) near/2 stress*) and
(expos* or psyc*)) ) Results: 2341°
Set#: S6 Searched for: ti((traumatised near/2 (victim* or survivor*)) ) OR ab((traumatised near/2 (victim* or survivor*)) ) Results: 84°
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Set#: S7 Searched for: ti((trauma* near/3 (event* or memor* or flashback* or nightmare*)) ) OR ab((trauma* near/3 (event* or memor* or
flashback* or nightmare*)) ) Results: 6974°
Set#: S8 Searched for: ti(((trauma* or posttrauma* or post-trauma* or victim* or survivor*) and (exposure near/4 (therap* or psychotherap*
or training or counsel*))) ) OR ab(((trauma* or posttrauma* or post-trauma* or victim* or survivor*) and (exposure near/4 (therap* or
psychotherap* or training or counsel*))) ) Results: 787°
Set#: S9 Searched for: ti((critical incident near/2 (stress or debrief* or de-brief*)) ) OR ab((critical incident near/2 (stress or debrief* or de-
brief*)) ) Results: 385°
Set#: S10 Searched for: ti((debriefing or de-briefing)) OR ab((debriefing or de-briefing)) Results: 685°
Set#: S11 Searched for: ti((crisis intervention* or CISD)) OR ab((crisis intervention* or CISD)) Results: 784°
Set#: S12 Searched for: ti(((stress or group* or psychological or crisis) near/4 (debrief* or de-brief*)) ) OR ab(((stress or group* or
psychological or crisis) near/4 (debrief* or de-brief*)) ) Results: 464°
Set#: S13 Searched for: ti((trauma* near/3 (event* or memor* or flashback* or nightmare*)) ) OR ab((trauma* near/3 (event* or memor*
or flashback* or nightmare*)) ) Results: 6974°
Set#: S14 Searched for: ti((EMDR or (eye movement desensitisation and reprocessing))) OR ab((EMDR or (eye movement desensitisation
and reprocessing))) Results: 888°
Set#: S15 Searched for: ti((EMDR or (eye movement desensitiZation and reprocessing))) OR ab((EMDR or (eye movement desensitiZation
and reprocessing))) Results: 888°
Set#: S16 Searched for: (s1 or s2 or s3 or s4 or s5 or s6 or s7 or s8 or s9 or s10 or s11 or s12 or s13 or s14 or s15)
Results: 36840*
Set#: S17 Searched for: MAINSUBJECT.EXACT("Randomized Clinical Trial") Results: 1210°
Set#: S18 Searched for: ab((randomized or randomised or placebo or randomly)) Results: 2931°
Set#: S19 Searched for: ti(trial) Results: 784°
Set#: S20 Searched for: (S17 or S18 or S19) Results: 3226°
Set#: S21 Searched for: S16 and s20 Results: 2654°
* Duplicates are removed from your search, but included in your result count.
° Duplicates are removed from your search and from your result count.
***************************
Appendix 3. Other database searches (Feb 2019)
In February 2019 a further (targeted) update search was conducted for RCTs, using search terms for condition and intervention.
Date of search: 22-February-2019
1. CENTRAL, (2018 to Issue 2, 2019), n = 145
2. MEDLINE (2018 to 21-Feb-2019), n = 39
3. Embase (2018 to 2019, week 07), n = 64
4. PsycINFO (2018 to February Week 1, 2019), n = 45
5. PTSDpubs (2018 to 22-Feb-2019), n = 24
6. PTSDpubs (Dissertation & Theses) (all years to date), n = 78
7. Trial Registries (all years to date), n = 19
[The Proquest database PILOTS was renamed to PTSDpubs in January 2019]
Total = 414
Duplicates removed = 87
To Screen, n = 327
Cochrane Central Register of Controlled Trials (CENTRAL) Issue 2 of 12, 2019
#1 MeSH descriptor: [Couples Therapy] this term only
#2 ((“Group Therapy") or (Psychotherapy near/2 Group)) and (couple* or partner* or marriage or marital or husband* or wife or wives* or
spous* or family or families or multi-family or conjoint or interpersonal or relations* or significant other or (child* and parent*)):TI,AB,KW
#3 ((couple* or partner* or marriage or marital or husband* or wife or wives* or spous* or family or families or multi-family or conjoint
or interpersonal or relations* or "significant other" or (child* NEAR parent*)) NEAR/3 (therap* or psychotherap* or counsel* or treat* or
intervention*)):TI,AB,KW
#4 (#1 OR #2 OR #3)
#5 MeSH descriptor: [Trauma and Stressor Related Disorders] explode all trees
#6 (PTSD or ((posttrauma* or post-trauma* or post trauma*) NEAR (stress* or disorder* or psych* or symptom*)) or ("acute stress" NEXT
disorder) or (combat NEXT disorder*) or (war NEXT neuros*)):TI,AB,KW
#7 (#5 or #6)
#8 (#4 and #7) n = 468 trials
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)









Cochrane Database of Systematic Reviews
Date limited 01/01/2018 to 22/02/2019, n = 145
***************************
Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily <1946 to February 21, 2019>
Search Strategy:
--------------------------------------------------------------------------------
1 exp Couples Therapy/ (2063)
2 Psychotherapy, Group/ and (couple* or partner* or marriage or marital or husband* or wife or wives* or spous* or family or families or
multi-family or conjoint or interpersonal or relations* or significant other or (child* and parent*)).ti,ab,kf,hw. (4836)
3 ((couple* or partner* or marriage or marital or husband* or wife or wives* or spous* or family or families or multi-family or conjoint
or interpersonal or relations* or significant other or (child* and parent*)) adj7 (therap* or psychotherap* or counsel* or treat* or
intervention*)).ti,ab,kf. (125231)
4 or/1-3 (128970)
5 Stress Disorders, Post-Traumatic/ (29434)
6 (PTSD or ((posttrauma* or post-trauma* or post trauma*) adj3 (stress* or disorder* or psych* or symptom?)) or acute stress disorder* or
combat disorder* or war neuros*).ti,ab,kf. (34083)
7 5 or 6 (42315)
8 randomized controlled trial.pt. (476462)
9 controlled clinical trial.pt. (92918)
10 (randomized or randomised).ti,ab,kf. (560894)
11 (RCT or randomized or randomised).ti,ab,kf. (564299)
12 randomly.ab. (305737)
13 placebo.ab. (195505)
14 clinical trials as topic.sh. (186060)
15 trial.ti. (194452)
16 or/8-15 (1241438)
17 4 and 7 and 16 (345)
18 (2018* or 2019*).yr,dp,dt,ep,ez. (1671137)
19 17 and 18 (39)
***************************
Ovid Embase <1974 to 2019 Week 07>
Search Strategy:
--------------------------------------------------------------------------------
1 couple therapy/ (308)
2 group therapy/ and (couple* or partner* or marriage or marital or husband* or wife or wives* or spous* or family or families or multi-
family or conjoint or interpersonal or relations* or significant other or (child* and parent*)).ti,ab,kw,hw. (5920)
3 ((couple* or partner* or marriage or marital or husband* or wife or wives* or spous* or family or families or multi-family or conjoint
or interpersonal or relations* or significant other or (child* and parent*)) adj7 (therap* or psychotherap* or counsel* or treat* or
intervention*)).ti,ab,kw. (176198)
4 or/1-3 (179609)
5 posttraumatic stress disorder/ (53155)
6 (PTSD or ((posttrauma* or post-trauma* or post trauma*) adj3 (stress* or disorder* or psych* or symptom?)) or acute stress disorder* or
combat disorder* or war neuros*).ti,ab,kw. (43952)
7 5 or 6 (60139)
8 crossover-procedure/ or double-blind procedure/ or randomized controlled trial/ or single-blind procedure/ or (random* or factorial* or
crossover* or cross over* or placebo* or (doubl* adj blind*) or (singl* adj blind*) or assign* or allocat* or volunteer*).tw. (2112246)
9 4 and 7 and 8 (463)
10 (2018* or 2019*).dc,dd,dp,yr. (2088349)
11 9 and 10 (64)
***************************
Ovid PsycINFO <1806 to February Week 1 2019>
Search Strategy:
--------------------------------------------------------------------------------
1 couples therapy/ (4249)
2 family therapy/ or conjoint therapy/ or strategic family therapy/ or structural family therapy/ (21413)
3 marriage counseling/ (4677)
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4 (exp group psychotherapy/ or group intervention/) and (couple* or partner* or marriage or marital or husband* or wife or wives* or spous*
or family or families or multi-family or conjoint or interpersonal or relations* or significant other or (child* and parent*)).ti,ab,id,hw. (8496)
5 ((couple* or partner* or marriage or marital or husband* or wife or wives* or spous* or family or families or multi-family or conjoint
or interpersonal or relations* or significant other or (child* and parent*)) adj7 (therap* or psychotherap* or counsel* or treat* or
intervention*)).ti,ab,id. (142872)
6 or/1-5 (148986)
7 posttraumatic stress disorder/ or complex ptsd/ or desnos/ (30247)
8 post-traumatic stress/ or acute stress disorder/ (897)
9 exp Combat Experience/ or exp Traumatic Neurosis/ (3032)
10 (PTSD or ((posttrauma* or post-trauma* or post trauma*) adj3 (stress* or disorder* or psych* or symptom?)) or acute stress disorder*
or combat disorder* or war neuros*).ti,ab,id. (42801)
11 or/7-10 (45372)
12 clinical trials.sh. (11241)
13 (randomi#ed or randomi#ation or randomi#ing).ti,ab,id. (77564)
14 (RCT or at random or (random* adj3 (assign* or allocat* or control* or crossover or cross-over or design* or divide* or division or
number))).ti,ab,id. (87047)
15 (control* and (trial or study or group) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,id,hw. (26945)
16 ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,id. (24877)
17 trial.ti. (27336)
18 placebo.ti,ab,id,hw. (38406)
19 treatment outcome.md. (19321)
20 treatment eGicacy evaluation.sh. (22634)
21 mental health program evaluation.sh. (2057)
22 or/12-21 (177418)
23 6 and 11 and 22 (374)
24 (2018* or 2019*).yr,an. (164112)
25 23 and 24 (45)
***************************
PTSDPubs (formerly PILOTS) (22-February-2019)
S1 MAINSUBJECT.EXACT("Conjoint Therapy") OR MAINSUBJECT.EXACT("Family Therapy") OR MAINSUBJECT.EXACT("Behavioral Couples
Therapy”) 622
S2 MAINSUBJECT.EXACT.EXPLODE("Group Psychotherapy”) AND noI((couple* OR partner* OR marriage OR marital OR husband* OR wife
OR wives* OR spous* OR family OR families OR multi-family OR conjoint OR interpersonal OR relations* OR “significant other” OR (child*
AND parent*))) 648
S3 noI(((couple* OR partner* OR marriage OR marital OR husband* OR wife OR wives* OR spous* OR family OR families OR multi-family
OR conjoint OR interpersonal OR relations*) N/3 (therap* OR psychotherap* OR counsel* OR treat* OR intervention*))) 2241
S4 noI(("significant other") N/3 (therap* OR psychotherap* OR counsel* OR treat* OR intervention*)) 3
S5 noI((parent*) N/3 (therap* OR psychotherap* OR counsel* OR treat* OR intervention*)) AND noI((child*) N/3 (therap* OR psychotherap*
OR counsel* OR treat* OR intervention*)) 187
S6 (S1 OR S2 OR S3 OR S4 OR S5) 2775
S7 MAINSUBJECT.EXACT("Randomized Clinical Trial”) 1302
S8 MAINSUBJECT.EXACT("Clinical Trial”) 270
S9 MAINSUBJECT.EXACT("Treatment EGicacy”) 5692
S10 noI((randomized or randomised or randomization or randomisation or randomizing or randomising)) 2453
S11 noI(RCT or “at random”) OR noI(random* N/3 (assign* or allocat* or control* or crossover or cross-over or design* or divide* or division
or number)) 2041
S12 noI((control* and (trial or study or group) and (placebo or waitlist* or wait* list*))) OR noI((control* AND (trial or study or group)))
and noI( (treatment N/2 usual) or (care N/2 usual)) 870
S13 ti(trial) 862
S14 ti(placebo) OR ab(placebo) 530
S15 (S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14) 6921
S16 (S6 AND S15) 753
S17 MAINSUBJECT.EXACT.EXPLODE("PTSD") OR MAINSUBJECT.EXACT.EXPLODE("Acute Stress Disorder") OR
MAINSUBJECT.EXACT.EXPLODE("Traumatic Neuroses”) 40082
S18 noI(PTSD) OR noI((posttrauma* OR post-trauma* OR "post trauma*") N/3 (stress* OR disorder* OR psych* OR symptom*)) 41658
S19 noI((“acute stress disorder*” or “combat disorder*” or “war neuros*”)) 1633
S20 (S17 OR S18 OR S19) 43415
S21 (S16 AND S20) 592
S22 (S16 AND S20) [Date] Limits Applied (2018-2019) 24
S23 (S16 AND S20) [Publication Type] Limits Applied (Dissertations & Theses) 78
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S24 (S22 OR S23) 102
***************************
Clinical Trials Registers (22-February-2019)
ClinicalTrials.gov n = 13
Advanced Search > Interventional Studies
Condition: PTSD OR "posttraumatic stress" OR "post traumatic stress"
Other terms: “Couple Therapy” OR “Couples Therapy” OR “Conjoint Therapy” OR “Family Therapy” OR “Families Therapy”
Other synonyms applied:
Condition: post-traumatic stress disorder, post-traumatic neuroses, combat fatigue, combat neuroses, post traumatic stress syndrome,
traumatic neurosis
Intervention: counseling families, family counseling, family psychotherapy
WHO International Clinical Trials Registry Platform (ICTRP) n = 6
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
The diGerences between protocol and review are as follows.
1. We excluded two databases: Web of Science and LILACS. AIer piloting the search we found that they did not add any relevant studies
to the screening but resulted in a large number of irrelevant publications.
2. We added search term "significant other".
3. We changed the primary outcome ‘severity of psychological symptoms of family members’ to two separate primary outcomes: ‘family
member severity of depression’ and ‘family member severity of anxiety’. It is anticipated that identical psychological measures would
be administered to both the primary participant and the family member within each study and the revised outcomes now better reflect
the current and future studies included in the review.
4. We amended comparison 3 to better reflect the published literature by replacing 'individual psychological therapy' with 'intervention'.
5. We did not include a follow-up assessment for any of the outcomes aIer post-treatment. Given that there was only one study in each
comparison, the follow-up assessments would not have added the intended value to the analyses. We will consider adding this in when
more studies become available.
6. We added Stephanie Taplin as an author.
Couple and family therapies for post-traumatic stress disorder (PTSD) (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
55
